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Summary – main trends and developments
Epidemiology 
Drug use among young people
Two surveys in 2006, both conducted in the same manner, one among  the 15-20 age group, and
one among young adults aged 21-30  showed major differences both in terms of  both lifetime
prevalence and use during the past six months of all types of drugs. The levels for 21-30 year-olds
are more than twice as high as for 15-20 year-olds, both in Norway as a whole and in Oslo.  And
while lifetime prevalence has increased strongly among young adults during the period 1998-2006,
the opposite has happened among young people under the age of 20. 
For cannabis, it can be concluded that experimentation is most frequent from the late teenage years
and into the twenties. Here, prevalence is still on the increase, while new recruitment among the
very youngest appears to be declining. As regards recent use of cannabis, these surveys cannot sub-
stantiate that there has been a definite increase among young adults. The data display a high degree
of stability. The decrease in “use during the past six months” among 15-20 year-olds is more strik-
ing, a decrease that has been fairly pronounced since the turn of the millennium.  
For other drugs, it is more problematic to identify clear trends, since so few people report use and
random factors can go in both directions. Among young people under the age of 20, lifetime preva-
lence for amphetamine, cocaine and ecstasy, the three most reported drugs, appears to have
declined during the period 1998-2006. Among young adults, the opposite trend is even clearer. In
an eight-year perspective, lifetime prevalence for all the three drugs has increased considerably; for
amphetamine it has doubled and for cocaine it has increased even more. But the prevalence for use
during the past six months has not increased, with the exception of cocaine, which has seen a dou-
bling during the last four years. The biggest increase in the use of cocaine is among men in Oslo.  
Drug-related infectious diseases
The number of HIV cases among injecting users remains low. In 2006, only 7 new cases (3 % of the
total number of HIV cases) concerned injecting users. The proportion that has developed AIDS is
somewhat higher (13 %), but the number remains low and stable. 
The hepatitis B outbreak continued, and 74 of a total of 149 cases of acute hepatitis B in 2006 were
among injecting drug users. During the period 1995-2006, the total number of reported cases of
acute hepatitis B among injecting drug users was 1 812. Hepatitis C is not monitored to the same
extent as hepatitis A and B, and the number of new cases of drug users being infected with the hep-
atitis C virus in Norway is therefore still not known.
Drug-related deaths
There are two bodies that register drug deaths, Statistics Norway and the National Crime
Investigation Service - Kripos. Both series of figures peak in 2001 and decline thereafter. According
to the statistics from Kripos, 195 persons died as a result of drug use in 2006, 11 more than in 2005.
Oslo had most: 72 deaths (2005:78). The 2006 figures from Statistics Norway are not yet available. 
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The statistics from Kripos also show that 72 per cent of the deceased in 2006 were under the age
of 40, while just over 20 per cent were under the age of 25. The percentage of drug-related deaths
among the youngest group (15-25 years) has remained relatively stable, although disturbingly high,
since the turn of the millennium.
Drug Markets
In 2006, the highest number of cases and seizures for four years was registered. The number of
seizures of cannabis and cocaine is the highest ever. A record amount of amphetamine was seized
in 2006.  
For methamphetamine, the trend is still moving steeply upwards. The number of seizures has almost
tripled since 2001. Methamphetamine also accounts for the biggest change in terms of positive
findings for illegal substances in road traffic cases, from slightly less than 10 per cent positive in
2003 of the total number of cases received to almost 20 per cent positive finds in 2006. 
Norway is probably one of the biggest markets for methamphetamine in Europe, with respect to
both the amounts seized and the number of seizures. Most of the methamphetamine comes from
illegal laboratories in Russia, Poland and Lithuania. Lithuania has probably taken over the role of
main supplier of synthetic drugs such as amphetamine, methamphetamine and Rohypnol to
Norway. Poland and the Netherlands are still important countries, but the majority of those arrest-
ed are Lithuanians.
On the basis of the seizures, the availability of cannabis still appears to be great. Cannabis was
seized in all the 27 police districts in 2006. Twenty-one police districts have made more seizures than
in 2005, and many of them have experienced an increase of between 20 and 80 per cent in the
number of seizures compared with 2005.
In 2006, cocaine was registered in all the police districts. There are many indications that cocaine is
more widespread geographically than ever before, both in terms of absolute figures and in relation
to other drugs. The amount of unreported cases/use may be particularly large since cocaine is often
used in nightlife arenas where the police are seldom or never present. 
The number of heroin seizures in 2006 was the lowest for 15 years, and the number has been more
than halved since 2001. Although the reduction is an indication that the demand for heroin has fall-
en substantially, the reduction in recent years is nonetheless so marked that doubts can be raised
about whether the seizure statistics reflect the situation on the street with respect to availability.
Kripos also claims that it has no reason to believe that the availability of heroin has been reduced in
relation to previous years. 25 of 27 police districts made seizures in 2006. Interviews among inject-
ing drug users in Oslo conducted by SIRUS as part of the mapping of the illegal street market do
not indicate that it has become more difficult to obtain heroin in the Oslo area.  The estimated price
level for heroin on the street also appears to remain quite unchanged. 
Legal framework/policies/strategies
The Temporary Act no. 64 of 2 July 2004 relating to a trial scheme for premises for the injection of
drugs (the injection room scheme) has beenprolonged. It has been decided to extend the period dur-
ing which the temporary act will be in force by two years, until 16 December 2009. The reason for
the extension is to ensure that there is sufficient time to assess the results of the evaluation of the
scheme, for which SIRUS is responsible, and to assess and, if applicable, draft a proposal for the per-
manent regulation of this service before the Act ceases to apply. 
In October 2007, as part of its budget proposal, the Government presented an escalation plan for
the drugs and alcohol field It consists of goals and measures in the whole drugs and alcohol field
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and ranges from prevention to treatment and rehabilitation. The plan, which will apply until 2010,
deals with both alcohol and drugs policy and national and international measures. The aim of the
plan is a policy with a clear public health perspective. The aim is to raise professional standards
through research and strengthening competence and quality. The escalation plan will be formally
adopted when the national budget for 2008 is considered by the Storting in December 2007. 
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Part A: New developments and trends
1. National policies and context
1.1 Legal framework
The temporary Act relating to injection rooms1 has beenprolonged (see NR.2 2004 chapter 1.1). It
has been decided to extend the period during which the temporary act will be in force by two years.
The Act will therefore be in force until 16 December 2009. The reason for the extension is to ensure
that there is sufficient time to assess the results of the evaluation of the scheme, for which SIRUS is
responsible, and to assess and, if applicable, draft a proposal for the permanent regulation of this
service before the Act ceases to apply. 
1.2 Institutional framework, strategies and policies 
The Minister of Health and Care Services has overall responsibility for drugs and alcohol policy in
Norway and for coordinating efforts in the field. Drugs and alcohol policy involves several different
sectors and requires coordination across ministry and agency boundaries. In Norway, moreover, there
is also a tradition for viewing drugs policy and alcohol policy as one integrated field. There is there-
fore one combined drugs and alcohol policy and corresponding action plan, rather than one alco-
hol policy and a separate drugs policy.
In addition to the Ministry of Health and Care Services, the most involved ministries are the Ministry
of Labour and Social inclusion, the Ministry of Children and Equality, the Ministry of Justice and the
Police, the Ministry of Local Government and Regional Development and the Ministry of Education
and Research. The respective directorates, the Norwegian Institute for Alcohol and Drug Research,
AS Vinmonopolet, the county governors and the regional drugs and alcohol competence centres all
have important responsibilities in the field of drugs and alcohol policy. Good contact and coopera-
tion between the different bodies is emphasised. 
1.2.1 Escalation plan for the drugs and alcohol field in Norway
In October 2007, as part of its budget proposal, the Government presented an escalation plan for
the drugs and alcohol field3. It consists of goals and measures in the whole drugs and alcohol field
and ranges from prevention to treatment and rehabilitation. The plan, which will apply until 2010,
deals with both alcohol and drugs policy and national and international measures.
The aim of the plan is a policy with a clear public health perspective. The aim is to raise profession-
al standards through research and strengthening competence and quality.
As regards services, the principle is that the ordinary services will also be available to people with
drug or alcohol problems. In its nationwide review and assessment of the Administrative Alcohol
and Drugs Treatment Reform in 2006 and 2007, the Norwegian Board of Health points to challenges
and needs in the drugs and alcohol field – not least with respect to the need for cooperation
between different bodies and administrative levels. The escalation plan addresses these challenges.
The user perspective is also a central element in the plan. The overriding goals are: 
1 Temporary Act no. 64 of 2 July 2004 relating to a trial scheme for premises for the injection of drugs (the injection room
scheme)
2 NR = National report
3 The action plan discussed in NR 2006 chapter 1.2 has been withdrawn.
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1. A clear public health perspective
2. Better quality and increased competence
3. More accessible services and increased social inclusion 
4. Binding cooperation
5. Increased user influence and greater attention to the interests of children and family members
The plan must be seen in conjunction with the Government’s special efforts in the fields of poverty,
housing, work and mental health, which also have a bearing on the drugs and alcohol field. In order
to achieve the goals of the escalation plan, the Government will, among other things:
• Strengthen the municipalities’ follow-up work, create more treatment places for interdiscipli-
nary specialist treatment and cut waiting times for treatment
• Ensure that everyone has an individual plan
• Carry out trial schemes with coordinating “representatives” for drug addicts and alcoholics
• Establish drugs and alcohol advisers under the auspices of the county governors
• Improve the quality of the services by introducing quality indicators, mapping tools, guides and
professional guidelines
• Introduce a waiting time guarantee for children and young drug addicts and alcoholics under
the age of 23
• Produce guides for the services about children of the mentally ill and drug addicts and alco-
holics
• Improve knowledge about children who need help, draw up a strategy for early intervention
and strengthen the regional child welfare service
• Quantify unsatisfied needs in the municipalities and in the specialist health service
• Award a youth prevention prize
The escalation plan will be presented to the Storting for consideration in autumn 2007 as part of
Proposition no.1 to the Storting (2007–2008) for the Ministry of Health and Care Services. 
Implementation of policies and strategies
The Directorate for Health and Social Affairs is an executive and advisory body in the field of drugs
and alcohol policy. The Directorate is responsible for implementing large areas of the drugs and alco-
hol policy and for maintaining an overview of the drugs and alcohol situation at the regional and
local levels. It also allocates grants to voluntary organisations in the drugs and alcohol field.
Responsibility for interdisciplinary specialist treatment has been assigned to the regional health
authorities. Norwegian drugs and alcohol policy is decentralised to a great extent, and the munici-
palities have a considerable responsibility for prevention, rehabilitation and reintegration of drug
addicts and alcoholics in the local community. 
The Directorate for Health and Social Affairs will have a large part of the responsibility for imple-
mentation of the proposed escalation plan for the drugs and alcohol field and will have chief respon-
sibility for many of the proposed measures. Continual follow-up during the plan period will be
ensured through collaboration between the ministries involved. The plan assigns chief responsibility
for each measure to a specific body. That body will be responsible for instigating measures and
involving affected parties. The body with chief responsibility will also be responsible for reporting. In
other respects, the general division of responsibility in the public administration will apply.  
Evaluation of policies and strategies
A number of the measures in the escalation plan will be specified in more detail during the plan peri-
od. In order to ensure systematic development and implementation, a scheme will be established
for coordination meetings between affected ministries and relevant subordinate agencies. The
Ministry of Health and Care Services will be in charge of coordination, and it will also be responsi-
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ble for coordinating the escalation plan with other plans. The status and progress of the different
measures will be reported annually to the Ministry of Health and Care Services, and this reporting
will form the basis for an annual summary of the attainment of goals and the progress of the meas-
ures.  
In connection with the Directorate for Health and Social Affairs’ grant schemes, great emphasis is
placed on evaluating the measures and earmarking funding for the evaluation of measures. The aim
is that this will contribute to improving the quality of the measures. Within the limits of the grant
schemes, it is seen as being important to support knowledge-based strategies and measures that
have continuity and local roots.
1.2.2 New centre for research on drugs and alcohol and addiction 
In autumn 2006, the Research Council of Norway advertised funding for a university-affiliated
research centre for drugs and alcohol research. The University of Oslo was awarded the centre on
20 June 2007, and it will build on the existing Unit for Addiction Medicine, which is affiliated to the
Faculty of Medicine. 
The main emphasis of the research centre will be on clinic-related drugs and alcohol research, and,
in addition to research and network building, it will also offer teaching and supervision of Master’s
degree students and doctoral students in the field. The research at the centre will be organised into
four research teams: 
1) The development of drugs and alcohol use and addiction, 
2) Problems and illnesses related to problem drugs and alcohol use, 
3) Treatment and intervention research, 
4) Health services related to the treatment of problem users of drugs and alcohol. 
The centre will cooperate closely with SIRUS – the Norwegian Institute for Alcohol and Drug
Research and with the National Institute of Public Health. 
A grant has been allocated for an initial period of up to five years with the possibility of an exten-
sion for a corresponding period.
1.3 Budget and public expenditure
Law enforcement.
See selected issue Public expenditure.
Social and health care
Alcohol and drug-related tasks are part of the ordinary services. Isolating and quantifying costs from
the social and care services that relate to drug addicts is highly complicated, and such figures can
therefore often be misleading.
In 2006, the cost of interdisciplinary specialist treatment for problem drug and alcohol users is esti-
mated to amount to EUR 262.5 million4 (NOK 2.1 billion) of the regional health authorities’ budg-
ets. The figure includes the treatment of both alcoholics and drug addicts. However, the estimate
only includes institutions specifically aimed at drug addicts and alcoholics. The costs of drugs and
alcohol treatment at other institutions are included under other functions (for example mental
health care). These costs cannot be quantified, but they come in addition.  
4 Conversion rate 1 EUR=NOK 8.00
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Research 
State funding is allocated annually to SIRUS and other research milieus (Table 1). 
Table 1. Funding for research and dissemination purposes in 2006. Figures in EUR and (NOK)  millions.
SIRUS 4.125 (33)
The Behavioural Centre 0.375 ( 3)
National Institute of Public Health* 1.25 (10)
The research programme – Research Council of Norway/ University of Oslo 1.875 (15)
Unit for Addiction Medicine, University of Oslo 0.625 (5)
Drugs and alcohol research conducted by the regional health authorities* 1.125 (9)
Total 9.375 (75)
*Approximate figure
The regional drugs and alcohol competence centres. Allocation for 2007: EUR 8.1 million (NOK 64.1
million).  
The competence centres are an important link between the state and municipalities and regional
health authorities with respect to both the dissemination and implementation of research-based
knowledge and recognised methods. They have three main purposes:
• to stimulate the development of preventive measures in the municipalities
• competence-building in the municipalities and the specialist health service
• to develop national areas of expertise
The most important users of the centres’ services are employees in municipal services and the spe-
cialist health service. 
International actions
Grant for 2007 to UNODC5: EUR 3 million (NOK 24 million).
Special grant schemes 
In addition to the ordinary block grant funding allocated to municipalities and health authorities,
funds are channelled to specially-prioritised purposes through grant schemes that are largely admin-
istered by the Directorate for Health and Social Affairs.  The grant schemes are divided between two
items on the national budget for 2007: 
Grants for municipal drug and alcohol measures – EUR 21.591 million (NOK 172.73 million).
Among other things, grants shall be used to strengthen personal guidance and individual follow-up,
low-threshold health measures for alcoholics and drug addicts, a trial scheme for injection rooms,
dental services for people with drug or alcohol problems and publications such as
“=Oslo”(Norwegian equivalent of “Big issue” in UK). 
Voluntary drug and alcohol prevention work etc.: EUR 14.971 million (NOK 119.774 million). Grants
are earmarked for follow-up, care and rehabilitation services run by voluntary organisations and pri-
vate undertakings, self-help and interest groups and work among family members, measures aimed
at prostitutes and grants to the street hospital in Oslo. In addition, EUR 444,425 (NOK 3.554 mil-
lion) is channelled through the regional drug and alcohol competence centres to stimulate the
municipalities and specialist health service. 
5 United Nations Office for Drugs and Crime
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The grant scheme Measures among children and young people in large towns and cities is admin-
istered by the Ministry of Children and Equality. Grants are given to 23 urban municipalities for
youth measures and, in 2007, they amount to EUR 2.19 million (NOK 17.5 million).  These meas-
ures should target youth groups and youth milieus that are deemed to be at risk. Young people from
immigrant backgrounds face particular challenges, and measures that promote integration are given
high priority. These measures will specifically target young people who make little use of existing
cultural and leisure services and provide better opportunities for qualification, inclusion and coping.  
1.4 Social and cultural context
Public opinion on drug issues  
In recent years, no specific opinion surveys have been carried out on the population’s views on drugs
policy. There is nonetheless reason to believe that there is relatively extensive support for the current
policy. Although certain groups advocate a more liberal drugs policy, this is seen as being a margin-
al view. Opinion is evolving, however, and an acceptance is gradually emerging for harm reduction
measures, but without this changing the ideal goal of freedom from drugs. There is also broad polit-
ical agreement about the main aspects of drug policy.
Attitudes to drugs and drug users
Attitudes to the use of drugs among young people are still predominantly negative. Surveys among
young people, particularly in relation to cannabis, confirm the tendency that the proportion express-
ing a positive attitude to drugs is no longer increasing. During the last two to three years, approxi-
mately 6 to 8 per cent of 15-20 year-olds nationwide have expressed the opinion that it should be
permitted to sell cannabis freely here in Norway. In the 21-30 age group in 2006, this proportion
was 10 per cent, the same proportion as eight years ago. However, there are more young adults
who would have tried cannabis if there was no risk of being arrested. The proportion in this context
has varied between 13 and 19 per cent from 1998 to 2006.  
There is great acceptance and sympathy among the general population for the view that drug
addicts and alcoholics need and should be given help. In large towns and cities where drug addicts
congregate, this view often has two elements: that these people need and deserve help, and that
they are to a certain extent an annoyance factor viewed with a certain amount of fear. Surveys car-
ried out by the police (in Oslo), however, show that this fear is largely unfounded. 
Initiatives in parliament and civil society
No new information available. 
Mass media campaigns
No major media campaigns have been conducted in 2006 targeting illegal drugs in particular.  
In order to increase awareness about the damage alcohol can result in and to increase knowledge
about which methods work best, the Directorate for Health and Social Affairs has carried out sepa-
rate campaigns during the past three years – www.settegrenser.no. These campaigns are followed
up at the local level, among other things through cooperation with the council of parents for pri-
mary and lower secondary schools. Young people and parents are particularly important target
groups and there must be agreement between the information aimed at these groups. In addition,
people from immigrant backgrounds and pregnant women are given priority. More emphasis will be
placed on adapting information to suit the section of the population at which it is aimed. Moreover,
the Directorate’s information efforts should support and strengthen the understanding that a restric-
tive alcohol policy is necessary.
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Action week to combat drugs
During a week in October every year, a number of voluntary organisations, schools and youth clubs,
the police, local help services, the business community and political youth organisations and many
others join forces to give an extra boost to the opposition to drugs. The action week in 2007 will be
the fourteenth in a row. 
In 2007, its profile is one of creating dialogue between youth and adults about drugs. At the same
time, it aims to help parents to talk with young people about drugs in a constructive manner. A sec-
tion of the action week’s website will be reserved for adults. In 2006, the action week held more
than 400 events throughout the country (www.actis.no).
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2. Drug use in the population 
2.1 Drug use in the general population
The most recent survey of the general population’s drug use was carried out by SIRUS in autumn
2004. The main results were discussed in NR 2005, chapter 2.1. The next nationwide survey is
scheduled for 2009. 
2.2   Drug use among youth and young adults  
Data from two new questionnaire surveys have been analysed in 2007: 
The use of drugs among young adults aged 21-30. Data from the years 1998, 2002 and 2006.
The use of drugs among students at the University of Oslo. The data are from 2006, and compar-
isons have been made with a corresponding survey in 1997.
In addition, data from 2006 are also presented from the annual questionnaire survey among young
people aged between 15 and 20. Since the division into age groups and questions about recent
drug use are not in harmony with the division used by the EMCDDA, the data cannot be included
in standard tables.  
2.2.1 Youth aged 15 – 20 
SIRUS conducts an annual questionnaire survey on the use of drugs among young people aged 15-
20 (Skretting, 2006). When these surveys first started in 1968, they only included youth in Oslo. A
corresponding survey was carried out in 1986 that covered the whole country, and since 1990 both
the nationwide survey and the Oslo survey have been carried out annually. The two sets of surveys
are conducted by sending the same questionnaire to two representative samples of youth aged
between 15 and 20, one sample that only includes youth registered as living in Oslo and one that
includes the whole country, including Oslo. 
Cannabis, primarily in the form of hash, is the drug most young people report having used.  After
peaking at the turn of the millennium, a certain reduction has been registered in recent years. The
percentage of 15-20 year-olds in Norway who state that they have ever used hash or marihuana has
been between 13 and 15 per cent during the last three years, while the proportion reporting hav-
ing used the drug during the last six months has been stable at around six per cent (Figure 1). The
corresponding percentages around the turn of the millennium were around 18 and 9-10 per cent,
respectively. Of course, the youngest age cohorts lower the average considerably. For 19-20 year-
olds, lifetime prevalence has been stable at around 25 per cent during the last three to five years.
For Oslo, the percentage reporting ever having used cannabis has fallen steadily in recent years and
in 2006 it was approx. 20 per cent, whereas approx. nine per cent reported that they had used
cannabis during the last six months. At the turn of the millennium, the corresponding percentages
were 28 and 16 per cent (Figure 2).
17
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Figure 1. The percentage of youth between the ages of 15 and 20 in NORWAY who state that they have used
cannabis: ever and during the last six months, respectively, 1986 - 2006.
Source: SIRUS
Figure 2. The percentage of youth between the ages of 15 and 20 in OSLO who state that they have taken
cannabis: ever and during the last six months, respectively, 1968 -2006(three- year sliding average).
Source: SIRUS
After increasing in the late 1990s, the proportion who state that they have used other drugs has
also largely stagnated/ declined in recent years (Figures 3 and 4). For example, the proportion of 15-
20 year-olds in the country as a whole who state that they have used amphetamine in the last two
to three years has been around 3 per cent, while the proportion stating that they have ever used
ecstasy has remained at around 2-3 per cent for several years. The corresponding figures for Oslo
are 2 - 4 per cent for amphetamine and the same for ecstasy. The decline appears to be somewhat
greater among young people in Oslo than in the country as a whole.
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Figure 3. Percentage of youth between the ages of 15 and 20 in NORWAY who have ever used various
drugs,1986 – 2006.
Source: SIRUS
Figure 4. Percentage of youth between the ages of 15 and 20 in OSLO who have ever used various drugs,1970
– 2006 (three-year sliding average).
Source: SIRUS
2.2.2 Young adults aged 21 – 30
In the years 1998, 2002 and 2006, SIRUS conducted questionnaire surveys for the 21 – 30 age
group on the use of drugs and other substances (Lund, Skretting 2007). The use of tobacco, alco-
hol, illegal drugs, medicinal drugs and anabolic steroids was included in the questions. The survey is
a supplementary survey to the annual youth surveys among the 15 – 20 age group. The survey was
conducted in the same manner, i.e. using a special sample which only includes those registered as
living in Oslo and a nationwide sample that also includes Oslo. 
Data and methods
The questionnaire was sent in the mail to a random sample. The nationwide sample consisted of 8
571 respondents for the three survey years (1998:3 455; 2002:2 731; 2006:2 385). The separate
sample for Oslo consisted of a total of 10 084 respondents (1998:3 241;2002:4 561; 2006:2 282).
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The response rate varied between 40 and 50 per cent. The questions have changed somewhat dur-
ing the three surveys years. However, most of the questions are the same and they thus provide a
good basis for studying changes over time. 
In both samples, there was a higher proportion of women than men, and a higher proportion of
older than younger respondents have answered the questionnaire. In the analyses, the two samples
are weighted for gender and age so that the distribution corresponds to the gender and age distri-
bution in the population for the different survey years, for the country as a whole and for Oslo in
particular. 
The use of cannabis 
Figure 5 shows that the proportion that have ever used cannabis in the nationwide sample has
increased from 22 per cent in 1998 to 30 per cent in 2002 and 34 per cent in 2006. A higher pro-
portion of men than women report having used cannabis at least once. In all the survey years, the
difference between the genders is approximately 10 percentage points (in 2006: 39 per cent men
and 28 per cent women p<0.01).
Figure 5. The proportion between the ages of 21 and 30 in NORWAY who state that they have ever used
cannabis, by gender and survey year. Percentage.
Source: SIRUS
In the Oslo sample, the proportion that has ever used cannabis is higher than in Norway as a whole.
Figure 6 shows that, for all respondents, the proportion was 35 per cent in 1998 and that it had
increased to 47 per cent in 2006 (p<0.001). The proportion is also more than twice as high among
15-20 year-olds (20 per cent in 2006). The gender difference in the Oslo sample was approx. ten
percentage points in all the survey years, the same as in the nationwide sample. In the 2006 survey,
53 per cent of men and 42 per cent of women stated that they had tried cannabis (p<0.001).
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Figure 6. The proportion between the ages of 21 and 30 in OSLO who state that they have ever used cannabis,
by gender and survey year. Percentage.
Source: SIRUS
Naturally, the intensity of cannabis use varies (Table 2). The highest proportions are those who have
only used the drug a few times and those who have used it more than 26 times. There is a tendency
that a larger proportion have used cannabis more than 26 times during the survey period. The pro-
portions are consistently higher in the Oslo sample than in the nationwide sample. 
Table 2. Proportion of the 21 – 30 age group in NORWAY and OSLO that have used cannabis a various num-
ber of times during their lives, by survey year. Percentage.
NORWAY OSLO
1998 2002 2006 1998 2002 2006
1-4 times 10 13 13 13 16 17
5-10 times 4 4 6 7 6 7
11 - 25 times 2 3 4 4 5 6
26 times or more 6 10 11 11 14 16
Source: SIRUS
As expected, the proportions who state that they have used cannabis during the past six months are
much lower than the proportions who state that they have ever used it (Figure 7). There has been
an increase from seven per cent in 1998 to ten per cent in 2002 and 2006. In 2006, there were
more than twice as many men (14 %) than women (6 %) who reported having used cannabis 
during the past six months (p<0.05). 
Figure 7. The percentage between the ages of 21 and 30 in NORWAY who state that they have used cannabis
during the past six months, by gender and survey year.
Source: SIRUS
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The proportion of the Oslo sample that have used cannabis during the past six months is also high-
er than the nationwide figure (Figure 8). In 2006, it was 15 per cent. The percentage has increased
somewhat during the period 1998 – 2006, but the increase is not significant. In 2006, 20 per cent
of the men in the Oslo sample and 11 per cent of the women reported having used cannabis dur-
ing the past six months (p<0.05). In 2006, of those who reported ever having used cannabis, 31 per
cent of the nationwide sample and 33 per cent of the Oslo sample also reported use during the past
six months. 
Figure 8. The percentage between the ages of 21 and 30 in OSLO who state that they have used cannabis dur-
ing the past six months, by gender and survey year.
Source: SIRUS
Debut age 
The results from the nationwide sample and the Oslo sample are very similar with respect to the pro-
portion that report having used cannabis at different ages. In 2006, approximately one in ten of
those who reported ever having used cannabis reported that they had made their debut when they
were 14 or younger. Roughly one in three had made their debut when they were 16 or younger.
The proportion that report having made their debut after reaching the age of 21 is declining, from
24 per cent nationwide in 1998 to 14 per cent in 2006, and in Oslo from 26 per cent in 1998 to 19
per cent in 2006. In this survey, the average debut age has declined from 18.8 years to 17.8 years
for the country as a whole and from 18.8 years to 18 years in the Oslo sample.
What characterises cannabis users?
Even though very many young people have now tried cannabis, most of them have only used it once
or just a few times. In the following, some characteristics are described of those who can be said to
be regular users: those who have reported using cannabis during the past six months. 
Table 3 shows that younger respondents reported having used cannabis during the past six months
to a greater extent than older respondents. In 2006, the proportion was 12 per cent among 21 –
25 year-olds and nine per cent among 26 – 30 year-olds. The relative difference is greater for women
than for men. In the separate Oslo sample, the differences between the age groups are greater than
in the nationwide sample. Among the 21 – 25 year-olds, 10 per cent reported having used cannabis
during the past six months, while the corresponding proportion was 13 per cent among 26 – 30
year-olds (not significant). In this sample, the differences were greater among women than among
men, both in 2002 and 2006.
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Table 3. The percentage between the ages of 21 and 30 in NORWAY and OSLO who state that they have used
cannabis during the past six months, by gender and survey year.
NORWAY OSLO
Women Men All Women Men All
1998 21 - 25 years 5 12 9 12 22 17
26 - 30 years 4 9 6 8 12 10
2002 21 - 25 years 7 17 12 13 23 18
26 - 30 years 5 11 8 8 17 13
2006 21 - 25 years 8 15 12 14 24 19
26 - 30 years 4 13 9 9 18 13
Source: SIRUS
Educational level
The proportion who have completed a university or university college education is somewhat lower
among those who have used cannabis during the past six months than in the sample as a whole.
The material thus points in the direction of a preponderance of people with lower secondary or
upper secondary school as their highest completed education among those who have used cannabis
during the past six months. In the nationwide sample, we find a clear difference with respect to
main occupation. It is those who are unemployed at the time of the survey who stand out from the
others and who have a particularly high proportion (23 per cent). We find corresponding significant
differences in the Oslo sample, in which the proportion of unemployed was 32 per cent. 
Income level
There are relatively big differences in the proportions that have used cannabis during the last six
months seen in relation to income. In the nationwide sample, there is a difference of six percentage
points between those who earn least and those who earn most. Moreover, the nationwide sample
and the Oslo sample follow each other to a great extent, but with higher proportions and greater
impacts in the Oslo sample than in the country as a whole. The EUR 12,500 to 25,000 income group
(annual income) come top in the Oslo sample with 21 per cent reporting having used cannabis dur-
ing the past six months. There is a relatively big difference between this group and the eight per
cent in the income group over EUR 50,000 (p<0.01). 
The use of other drugs
In addition to cannabis, questions were also asked about the use of amphetamine, ecstasy,
cocaine/crack, LSD, heroin, GHB6 and anabolic steroids. 
Norway as a whole
Figure 9 shows the percentages that have ever used various drugs in the three survey years in the
country as a whole. 
6 There were no questions about the use of GHB in 1998. 
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Figure 9. Proportion between the ages of 21 and 30 in NORWAY who have ever used various drugs, by survey
year. Percentage.
Source: SIRUS
Cocaine is the drug for which the increase has been greatest, from 3 per cent in 1998 to just under
9 per cent in 2006 (p<0.05). In 2006, the proportion of men (11.6%) who reported ever having
used cocaine in 2006 was roughly twice as big as the proportion of women (5.5%) (not significant). 
Lifetime prevalence for amphetamine has also increased during the period. In 1998: 5 per cent, in
2006: 9 per cent (not significant). It was asked about both amphetamine that was injected and
amphetamine taken in another form. The biggest proportion take amphetamine in another form
than by injecting. As is the case for cocaine, the proportion of men who reported ever having used
the drug is twice as large as the proportion of women.    
The use of ecstasy appears to have stabilised. Lifetime prevalence increased from 2.5 per cent in
1998 to almost 6 per cent in 2002, but only showed a marginal increase in 2006. Again, the pro-
portion of men is twice as high as the proportion of women. Moreover, the proportion reporting
ever having used heroin also appears to have stabilised. In 1998, less than one per cent had ever
used heroin, while in 2006 the proportion had increased to approx. 1.5 per cent. This percentage
includes both injection and smoking as the method of taking the drug. Of those who had used hero-
in, 1.5 per cent had smoked heroin and 0.5 per cent had injected it. A few have reported experi-
ence of both injection and smoking. People who have smoked heroin are probably registered to a
greater extent in this type of survey than injecting  drug users.
The proportion that report having used LSD has fallen somewhat, from just over 3 per cent in 2002
to just over 2 per cent in 2006. A question about the use of GHB was included in the survey from
2002. There has been a marginal increase in the proportion who report having used GHB, and this
proportion was +/- 2 per cent in both 2002 and 2006.
The Oslo sample
The reported use of amphetamine, LSD, cocaine and ecstasy is greater in Oslo than in the country
as a whole (Figure 10). The greatest increase in Oslo was also in the proportion reporting ever hav-
ing used cocaine. In 1998, just over 7 per cent reported ever having used cocaine, the proportion
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increased to just under 10 per cent in 2002, and in 2006 it had increased further to just under 14
per cent (p<0.05 from 1998 to 2006). In 2006, the proportion of men (18 %) who reported ever
having used cocaine was significantly greater than the proportion of women (10 %) (p<0.05). 
Figure 10. Proportion between the ages of 21 and 30 in OSLO who have ever used various drugs, by survey
year. Percentage. 
Source: SIRUS
The proportion who have ever used amphetamine increased from 10 per cent in 1998 to 11.5 per
cent in 2002 and to 12.5 per cent in 2006. The proportion who have ever used ecstasy continued
to increase somewhat, from 5.5 per cent in 1998 to 8.5 per cent in 2006. The proportion that
reported ever having used LSD is also greater in Oslo than in Norway as a whole. In 1998, it was 3.5
per cent, while the proportion in 2006 was almost 4.5 per cent. In Oslo, the proportion that report-
ed ever having used heroin was 1.5 per cent in 2006, roughly the same proportion as in Norway as
a whole. The proportion that reported having used GHB is the same in Oslo as in the country as
whole. The proportion in Oslo was relatively stable in the two survey years in which questions were
asked about the use of GHB, approx. 2.5 per cent. 
Recent use (in both samples)
Only a very small proportion reported having used various drugs during the past six months. 
With the exception of cocaine and amphetamine, the proportion was less than one per cent in both
the country as a whole and the Oslo sample. In the nationwide sample, the proportion that had used
amphetamine during the past six months fell from 2.5 per cent in 2002 to 2 per cent in 2006, and
in Oslo from 3.5 per cent to 2.5 per cent in 2006. On the other hand, the survey shows that recent
use of cocaine in the country as a whole increased from 2 per cent to approx. 4.5 per cent during
the same period. Most of those concerned have only tried cocaine a few times. Figure 11 illustrates
the frequency.  
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Figure 11. The number of times people between the ages of 21 and 30 in OSLO have used cocaine during the
past six months as a percentage, by gender and survey year (2002 and 20067).
Source: SIRUS
Statistical margins of error and other possible sources of error 
There are statistical margins of error attached to the figures in the two surveys (15-20 years and 21-
30 years), and they must be interpreted with caution. Moreover, questionnaire surveys are always
susceptible to certain sources of error (not everyone responds, some responses contain deliberate or
inadvertent errors etc.). The surveys also targeted young people in general. There is reason to believe
that young people who regularly use drugs, either cannabis or stronger substances, will be under-
represented in the surveys. Surveys of this type are therefore primarily suitable for telling us some-
thing about experimentation and recreational use. Another source of uncertainty is the fact that the
response rate for both surveys has been between 40 and 50 per cent in recent years. The purpose
of the surveys is primarily to serve as a tool for examining trends over time (Lund, Skretting 2007). 
2.2.3 Tendencies 
The two surveys show major differences both in terms of lifetime prevalence (LTP) and use during
the past six months of all types of drugs. Levels for 21-30 year-olds are more than twice as high as
for 15-20 year-olds, both in Norway as a whole and in Oslo.  And while LTP has increased strongly
among young adults during the last eight years, the opposite has happened among young people
under 20. 
The differences are probably largely due to the cumulative effect (‘if you have used once, then you
will always have used’). Cannabis use among 15-20 year-olds, for example, reached its highest level
so far around the turn of the millennium. This group is now part of the young adults group.
Moreover, a considerable number of people make their cannabis debut after reaching the age of 21.
Even though the proportion is falling, this factor helps to raise prevalence.  
The young adults survey includes ten year cohorts, while the youth survey includes six year cohorts.
By comparison, population surveys show that LTP is highest in the 25-34 age group and recent use
is most frequent among those between the ages of 20 and 24 (NR 2005, chapter 2.1). The youngest
members of the youth sample traditionally use drugs least and contribute to a lower average (cf.
data from ESPAD). A more-detailed breakdown of the age groups under 20 shows that LTP for 19-
20 year-olds has been relatively close to the level for the whole sample of young adults in recent
years. 
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For cannabis, we can conclude that experimentation is most frequent from the late teenage years
and into the twenties. Here, prevalence is still on the increase, while new recruitment among the
very youngest appears to be declining. As regards recent use of cannabis, these surveys cannot sub-
stantiate that there has been a definite increase among young adults. The data display a high degree
of stability. The decrease in “use during the past six months” among 15-20 year-olds is more strik-
ing, a decrease that has been fairly pronounced since the turn of the millennium.  
For other drugs, it is more problematic to identify clear trends, since so few people report use and
random factors can go in both directions. Among young people under the age of 20, LTP for
amphetamine, cocaine and ecstasy, the three most reported drugs, appears to have declined during
the period 1998-2006. Among young adults, the opposite trend is even clearer. In an eight-year per-
spective, LTP for all the three drugs has increased considerably; for amphetamine it has doubled and
for cocaine it has increased even more. But the prevalence for use during the past six months has
not increased, with the exception of cocaine, which has seen a doubling during the last four years.
The biggest increase in the use of cocaine is among men in Oslo.   
2.3 Drug use among specific groups
2.3.1 The use of drugs among students at the University of Oslo.
In 2006, 1 655 students at the University of Oslo took part in the project Studenter og Rusmidler
(Students and alcohol and other drugs), a questionnaire survey on the use of alcohol and other
drugs, smoking and gambling (Tefre, 2007). The results have been compared with findings from a
corresponding student survey in 1997. The overriding purpose of the project was to gain insight into
and knowledge about the extent of alcohol use, the use of other drugs, anabolic steroids and gam-
bling among students in 2006. The results of the project were to be compared with a similar stu-
dent survey in 1997.
Method and data basis
The criteria for belonging to the target group for the survey were to be the same as for the 1997
survey. Because of the language barrier, foreign students were excluded. The target group thus
numbered 13 070 students. Of these, 3 000 students were selected at random, who would be rep-
resentative in terms of gender, age and faculty.
A gross sample of 2 922 was arrived at and 1 679 of them responded. Twenty-eight responses had
to be left out because of missing information about gender, age and alcohol consumption. The final
number of questionnaires that form the basis for the statistical analysis was thus 1 655, or 57 per
cent of the actual gross sample. That is two per cent lower than for the previous survey. The decline
in the response rate was less than there was reason to fear given the general decline in response
rates that has characterised survey-based research. 
Illegal drugs – main findings
• The use of hash (ever) has increased from 1997 to 2006; use during the past six months has
not increased
• The use of cocaine and ecstasy (ever) has also increased
• The use of other drugs does not appear to have increased 
• Few respondents had used drugs during the past 12 months; hash is the most common drug 
• Approx. one in twenty has used legal medicinal drugs for intoxication purposes (ever) 
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Hash
As Table 4 shows, 35 per cent of the students had tried hash in 1997. Nine years later, 42 per cent
had done so. This represents an increase of 20 per cent. Since the use of hash is more common in
Oslo than in the rest of the country, it should be added that almost half of those who responded to
the survey in 2006 stated that they came from Oslo. Nor is it surprising that some of the students
who come from places other than Oslo adopt the urban youth culture in Oslo. 
Table 4. The use of hash 1997 and 2006 Both genders8. Percentage.
Type of drug Year Used ever/ number of times used Used during 
past 12
months
Never 1 - 5 times 6 - 50 times 51+ times
Hash 1997 65 19 11 5 14
2006 58 23 12 7 15 
Source: Tefre, E-SIRUS.
The difference between the number of times of use in 1997 and 2006 was significant, p<0.01, while
there was no significant difference in use during the past 12 months.
A large proportion try drugs once or just a few times. Almost half the students, 42 per cent, had
ever used hash, but experimental use (defined in the survey as 1-5 times) accounted for more than
half of this. Almost two in ten (19 per cent) had used hash more than five times and 15 per cent
had used hash during the past year. 
In 1997, 31 per cent of the women students had tried hash ever, while the figure in 2006 was 39
per cent, corresponding to an increase of 25 per cent. The proportion of male students who had
tried hash was 40 per cent in 1997 and 47 per cent in 2006, an increase of 17 per cent.  
In 2006, experimental use amounted to 23 per cent among women, while 16 per cent had used
hash more than that. At 22 per cent, the level of experimental use among men was almost the same
as among women, while 26 per cent of the men had used hash six times or more. Measured as a
proportion of hash users, experimental use was lower among men (47 per cent) than among
women (60 per cent), i.e. regular use was higher among men than among women. The extent of
hash use among students agrees well with the figures from SIRUS for young adults aged 21-30 in
Oslo (chapter 2.2.2).
Other drugs
Naturally, the use of all drugs other than hash is reported more rarely. Cocaine use showed the
greatest increase in this survey as well. In 2006, 8 per cent reported having used cocaine. More than
one in ten male students have ever tried cocaine, while 6 per cent og female students have used
the drug (Tables 5 and 6). In 1997, the proportion was 5 per cent for men and 2 per cent for
women. Experimental use is most common, and it has doubled since 1997, among both women
and men. Use during the past 12 months also doubled among both sexes between the two survey
years, although it must be stressed that the samples are small. 
8 The total figures for Oslo students are not weighted in relation to gender. The figures will thus be lower due to the high
percentage of women (64%) and higher due to fewer students in the highest age groups. 
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The use of amphetamine ever is close to the level for cocaine, 7 per cent in 2006. The proportion
also increased somewhat, but the difference is not so large as to rule out this being the result of
random effects in the measurements. It cannot, therefore, be claimed that there has been an
increase in amphetamine use from 1997 to 2006. In 1997, 4 per cent of women reported that they
had ever tried amphetamine, while 5 per cent reported the same in 2006. The figures for men were
7 per cent and 9 per cent, respectively. 
The use of ecstasy has increased somewhat in this survey. From 1997 to 2006, the reported use
increased (ever used) among students from two to four per cent. 
For more regular use, defined in the survey as more than six times, the samples are so small for all
drugs other than cannabis that it is impossible to prove any changes.  
Table 5. The use of illegal drugs among female students 1997 and 2006. Percentage. 
Have you used: Year Ever used During 
the past 
12 months
Never 1 - 5 times 6 - 50 times 51+ times 
Hash 1997 69 17.6 9.4 3.6 10.0 
2006 62 22.9 10.6 5.1 10.9 
Amphetam. 1997 96 2.8 0.8 0.3 1.6
2006 95 3.6 1.5 0.2 0.7 
Cocaine 1997 98 1.9 0.4 - 0.9
2006 94 4.4 1.2 0.3 1.9 
Heroin 1997 99 0.5 - 0.1 0.1
2006 99.5 0.4 0.1 - 0.1 
Ecstasy 1997 98 1.4 0.2 - 0.9
2006 96 2.7 0.6 0.3 0.2
Other drugs 1997
2006 95 4.5 0.6 0.3 0.6 
Source: Tefre E.-SIRUS
Table 6. The use of illegal drugs among male students. 1997 and 2006. Percentage.
Have you used: Year Ever used During 
the past 
12 months
Never 1 - 5 times 6 - 50 times 51+
Hash 1997 59.9 21.3 12.1 6.6 19.4
2006 52.9 21.6 14.7 10.8 22.0
Amphetam. 1997 92.7 5.0 1.9 0.4 2.8
2006 91.1 7.0 1.9 - 2.4
Cocaine 1997 95.2 3.9 1.0 2.1 -
2006 88.4 8.2 3.2 5.1
Heroin 1997 99.2 0.6 - 0.3 0.3
2006 99.5 0.5 - - -
Ecstasy 1997 96.7 2.6 0.6 0.1 1.1
2006 95.4 3.8 0.9 - 0.9 
Other drugs 1997
2006 89.2 8.8 1.9 0.2 2.8 
Source: Tefre, E.- SIRUS
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Medicinal drugs
In the questionnaire, it was up to the students themselves to assess what they would define as
medicinal drugs used for intoxication purposes. Medicinal drugs such as Valium, Rohypnol,
Mogadon and similar are the most commonly used drugs for this purpose. All together, a good 5
per cent had ever used a medicinal drug for intoxication purposes and slightly more than one per
cent had used such drugs during the past year, while four per cent had previously used such drugs.
Very few had used medicinal drugs for intoxication purposes very frequently (Tefre, 2007). 
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3. Prevention
3.1 Universal prevention
See information in Structured Questionnaire 22/259.
The Regional Project 
The municipalities are one of the most important arenas in the prevention field. Municipal preven-
tion efforts in the drugs and alcohol field include administering the Alcohol Act and in offering chil-
dren and young people attractive drug and alcohol-free activities and places to meet. In order to
encourage coordination and cooperation in the municipalities, the Regional Project was started in
nine pilot municipalities in 2004 (discussed in NR 2005, chapter 3.3). The intention was to develop
new measures and coordinate existing preventive efforts in the participating municipalities. The
experience gained will be communicated to other municipalities and form the basis for future local-
ly-based preventive work. The Regional Project is currently being evaluated by SIRUS. 
Local action plans
Given its objective of “reducing the harmful effects of alcohol to individual and society”, the Alcohol
Act and its pertaining regulations are, together with municipal licensing rules, a central policy instru-
ment in the alcohol field. The Alcohol Act gives municipalities considerable freedom to reduce the
harmful effects of alcohol, and responsibility for doing so. For instance, the Act obliges the munici-
palities to adopt action plans for alcohol policy. The Directorate for Health and Social Affairs has pro-
duced a guide that is intended to make it easier for municipalities to draw up such plans . The tar-
get group consists of municipal employees, planners and local politicians who are to consider such
plans. The guide provides facts and information about what should be emphasised in the work and
it contains references to other sources and aids. 
As an aid for use in planning work, a new website was launched in 2007: “Kommunetorget.no”.
This website is a practically-oriented guidance service, which aims to: 
• Strengthen control methods so that drugs and alcohol-related issues are dealt with in a pro-
fessional and expedient manner.
• Contribute to increasing the competence of municipal employees and local politicians about
drugs and alcohol-related prevention and treatment-related issues.
• Contribute to a holistic approach being taken in the different drug and alcohol-related plans.
The work on drug and alcohol policy action plans and individual plans for problem drug and alco-
hol users have a central place on the website. The website is intended to provide a professional
foundation for the planning and instigation of planning processes in the municipalities in addition
to illustrating practical experiences from various plan work and user experiences. 
9 All Structured questionnaires referred to have been submitted to the EMCDDA separately. 
31
E M C D D A  –  N A T I O N A L  R E P O R T  2 0 0 7
Early intervention 
Early intervention is on the borderline between prevention and treatment. Knowledge about what
to look for in order to identify possible drug and/or alcohol problems and how to proceed in order
to intervene varies from arena to arena and player to player. There is a good knowledge base in
some of these areas today. This applies, for example, to children of kindergarten and primary/lower
secondary school age and their families, and to adults with high-risk alcohol consumption. For these
user groups, the challenge primarily consists of making use of available knowledge. In relation to
other arenas/ target groups, knowledge is poorer and it is necessary to develop a better knowledge
base. This applies, for example, to work with young people in the age group 15 and older (Nesvåg
et al. 2007). 
In order to meet the need for a national strategy for early intervention in the drugs and alcohol field,
the Directorate for Health and Social Affairs has drawn up a proposal for a national strategy. The
following three main strategies are proposed in the report:  
1) Broad-based, overriding securing of early intervention in the drugs and alcohol field in a forum
in which the relevant ministries and directorates take part (coordination groups, for example). Link
early intervention efforts to the forthcoming escalation plan for the drugs and alcohol field. 
2) Selected priority areas. The following are proposed as the eight most important areas: 
• Children of parents with drugs and/or alcohol problems/ mental health problems 
• Youth at risk
• Youth admitted for alcoholic intoxication (poisoning)
• Pregnant women 
• General practitioners as an arena 
• Hospitals as an arena 
• The workplace as an arena 
• Schools as an arena
3) The instigation of long-term, purposeful efforts targeting selected groups and arenas and with
the same timeframe as the forthcoming escalation plan for the drugs and alcohol field. The work-
ing group proposes that overriding coordination groups be appointed for each of the priority areas,
led by the authorities and with representatives of key bodies at different levels as active participants.
It will be natural to draft action plans, goals and measures, for example through the production of
guides (Directorate for Health and Social Affairs, 2007). 
A more-detailed description of some of the target groups for early intervention is provided in chap-
ter 12. 
3.2 School programmes
Norwegian schools employ a number of different measures and programmes to reduce and prevent
problem behaviour. The evaluation of some of the programmes was discussed in NR 2006, chapter
3.2.1. Preventive efforts in schools should be knowledge-based, but it turns out that some of the
measures used are based more on good intentions than on a professional and empirical basis. A lot
of the work that is done and many of the measures instigated are not evaluated in a satisfactory
manner. 
In 2005, the Directorate for Health and Social Affairs and the Directorate for Primary and Secondary
Education therefore appointed four research teams who assessed 29 different programmes in the
field of problem behaviour, social competence and drug and alcohol preventive work in schools, 16
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of which concern drug and alcohol preventive work in schools (Nordahl et al., 2006). In the report,
great variations are pointed out between the different programmes. The best programmes built on
research-based knowledge, included evaluation of the programme, had a clear strategy for imple-
mentation and, as a rule, also had several theoretical approaches to the problem. The less satisfac-
tory programmes failed on several of these criteria. The programmes were assessed in accordance
with international standards and divided into three categories: 
1. Programmes with a low probability of having an effect: These programmes are characterised,
among other things, by good intentions, but have a poor basis in knowledge and they lack an
evaluation. Eleven programmes ended up in this category.
2. Programmes with a good probability of having an effect: These programmes are based on the-
oretical and/or empirical knowledge and have good implementation strategies, but lack evalu-
ation or have undergone an evaluation with significant deficiencies. Of the drugs and alcohol
programmes, three programmes were placed in this category. 
3. Programmes with documented effects: These programmes build on research-based knowledge,
have been properly tested and thoroughly evaluated, have clearly defined strategies for imple-
mentation over time and, as a rule, comprise all members of staff. Of the drugs and alcohol
programmes, it was the programmes: “Youth and Alcohol” and ”BeSmokeFree” that were
placed in this category. 
The drugs and alcohol field stood out in relation to other prevention areas in that there were few
programmes with documented results. Many programmes have unclear implementation strategies
and are based on short-term efforts. 
3.3 Selective prevention 
See information in Structured Questionnaire 26.
A summary of existing knowledge
A summary of existing knowledge about early intervention in the drugs and alcohol field carried out
by the International Research Institute of Stavanger (IRIS) on assignment for the Directorate for
Health and Social Affairs, shows that instigating early measures in relation to children of kinder-
garten and primary/lower secondary school age and their families produces results in terms of pre-
venting both drug and alcohol problems and mental health and social problems (Nesvåg et al.
2007). The same applies to early measures aimed at adults with high-risk alcohol consumption. 
Early help for children and their families can prevent both drug and alcohol problems and mental
health and social difficulties. Preventive measures in relation to groups at risk include measures that
target groups with certain characteristics and individuals who show early signs of problems. It is
important that such measures are instigated in relation to young people who are in danger of devel-
oping or reinforcing problem drug or alcohol use. The goal should be to halt the development of,
or a relapse into, problem behaviour and difficult life situations. The social services, child welfare
services and schools have a central role in this type of preventive work. 
The effective interventions aimed at children and their families are those that are based on obser-
vation, dialogue and advice given in the families’ home arena, and those that aim to stimulate chil-
dren’s intellectual development. Effective measures aimed at older children often combine the fam-
ily and the school arenas, and, to a certain extent, the local community. Effective programmes are
not just educationally oriented, but also emphasise training in the development of good coopera-
tive skills between adults and children. Examples include the Strengthening Families Program (SFP)
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and Multisystemic Therapy (MST) (NR 2006, chapter 3.5). The programmes are intended to strength-
en the family’s internal ties and ties to the local community, to teach parents to develop a dialogue
that balances care, the setting of limits and young people’s need to become independent, to
improve communication and conflict-management skills and to impart knowledge about children
and young people’s development.
As regards intervention efforts in relation to young people over the age of 15, there is a need for
methods in relation to both illegal drugs and the development of high-risk alcohol habits. IRIS rec-
ommends the development of measures that can communicate with youth in new ways, in new are-
nas and through new channels. It will be necessary to utilise a combination of professional health
and social competence, competence about youth culture and competence in communication and
the media in new and innovative ways (Nesvåg et al. 2007).
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4. Problem drug use and the treatment demand indicator
4.1 Prevalence and incidence estimates of problem drug use 
See the data in standard tables 07/0810.
In the EMCDDA context, problem use is defined as “Intravenous use of drugs or prolonged/regular
use of opiates, cocaine and/or amphetamines.” In Norway, we only have estimates for injecting
users. So far, data sources are lacking that can provide figures for prolonged/regular use of opiates,
cocaine and/or amphetamines. People in medically-assisted treatment, but who nonetheless inject
various drugs, are included in the injecting users group in the calculations. 
In NR 2006 chapter 4.1, figures were shown for the number of injecting users based on three meth-
ods: the Mortality Multiplier, questionnaire surveys sent to the police and the social services in the
municipalities and the Multiple Indicator Method for calculating intravenous use, i.e. persons who
at least once in the relevant year have taken drugs by injecting them, regardless of the drug
involved. Update for all three methods have not yet been carried out. However, insight into devel-
opments from 2004 to 2005 and 2006 can be based on those parts of the material that have been
analysed and on the change in other indicators that have previously been proven to correspond to
developments in injecting  use over time. 
The number of injecting drug users in Norway increased until 2001, after which time it declined until
2003 and then flattened out. Summarising estimates from three different methods, it was presumed
that there were approximately 8 200-12 300 injecting users in Norway11 in 2004. The main impres-
sion based on preliminary calculations and indicators is that there has been no marked change in
the number of injecting users in 2005 or 2006. 
The basis for this impression consists of overviews of drug deaths from the National Criminal
Investigation Service (Kripos), the Municipal Surveys from SIRUS in 2005 and 2006, the police and
customs authorities’ figures for seizures of heroin, cocaine and amphetamine/methamphetamine
(chapter 10.3) and the Institute of Public Health’s statistics for positive findings of heroin in road traf-
fic cases (chapter 8.2.3)
Development work is currently being done in SIRUS relating to the calculation of recruitment to
injecting use over time.
10 All Standard tables referred to have been submitted to the EMCDDA separately
11 The estimate has an upper limit higher than that which results from the Multiplier Method, but lower than that which
resulted from the Multiple Indicator Method and the Municipal Survey. This is because the latter two methods probably
produce figures that are too high.
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Table 7. The number of injecting  drug users in Norway 2002-2005. Three methods.
Municipal Multiple Indicator Mortality
Survey* Method* Multiplier
2002 15 394 15 456
(12 889-18 513) (11 885-19 027) 10 238 - 14 030
2003 15 322 16 215
(12 911-18 306) (14 801-17 629) 8 604 - 11 914
2004 16 335 15 690
(13 460-20 099) (14 062-17 319) 7 857 - 11 000
2005 16 888 14 406
(13 135-21 701) (13 232-15 580) 7 918 - 11 086
* Figures for Oslo have been estimated using the Mortality Multiplier.
Source: SIRUS
4.2 Treatment demand indicator
4.2.1 Client mapping data for 2006 
Norway has a national documentation system for use by the help services for problem drug and
alcohol users (see NR 2005 chapter 4.2). The system includes all treatment and care measures.
Participation in and use of the mapping forms has not been defined as mandatory by the authori-
ties in question, so that the individual measures have been permitted to not participate. Otherwise,
there is reason to believe that there are variations between the measures as regards how large a pro-
portion of the queries and admissions are covered by the client mapping system, and the extent to
which the whole mapping form is used for all clients. 
The data basis includes both alcoholics and problem drug users. Since the data is only available at
aggregate level, the overviews do not tell us how many individuals are involved in the number of
queries and admissions, which means that it is not possible to check for duplicate registrations. The
fact that the system is based on aggregate data also means that variables cannot be compared at
the individual level. These factors explain why the data cannot be included in the standard tables.
The individual variables can only be shown distributed by gender, geographical unit (region or coun-
ty) and type of measure. It is also possible to show the variables distributed by combinations of gen-
der, geographical unit and type of measure.  
Queries and admissions 
In 2006, 31 495 queries were registered, and 34 740 queries in 2004. The reduction is partly due
to a fall in participation; 107 measures submitted the client mapping form in 2004, compared with
98 in 2006. The gender distribution was 70 per cent men and 30 per cent women, roughly the same
as during the years 1998 to 2005. 
In 2006, a total of 21 987 admissions were registered in treatment/care measures, a reduction from
2004 (24 485). The reduction is due to the same factors as discussed in relation to queries.
The gender distribution, which was also 70/30 per cent for admissions, has been very stable in all
the survey years. 
Figure 12 shows the number of registered queries for women and men in various age groups. By far
the largest number of queries concerned the age groups 31 to 50 years. 
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Figure 12. Queries by age and gender 2006. Number of queries.
Source: The Bergen Clinics Foundation 
Education, income, social factors
As regards highest completed educational level, there is little difference from year to year. The
largest group, roughly 40 per cent, consists of those whose highest completed education is lower
secondary school. The picture is the same for women and men, with a tendency for a slightly larg-
er proportion of women than men to have lower secondary and upper secondary school as their
highest education, while a slightly higher proportion of men than women have occupational train-
ing as their highest education.
The social background variables paint a picture of a group of problem drug and alcohol users who
are not in employment and who are therefore dependent on public support. In 2006, as many as
77 per cent of the patients/ clients were neither in employment nor in education. The proportion
who were in full-time jobs was as low as 15 per cent, the lowest proportion observed since the doc-
umentation started. The picture is otherwise fairly similar from year to year. There is a tendency for
a somewhat larger proportion of men than women to be in full-time jobs, and for a higher propor-
tion of women than men to be in part-time jobs or in education. 
Social security (including single parent benefit) was the most important source of income for the
largest group during the first years of the 1999 to 2006 period, while a switch from social security
to temporary national insurance benefit means that temporary national insurance benefits are now
the most important type of income in recent years. This general tendency appears to continue in
2006. Whether the changes are due to differences between client samples from one year to the next
or whether they reflect actual trends is difficult to say on the basis of the available data. There are
very small gender differences as regards the most important source of income. The information
about income must also be seen in light of the fact that questions are not asked about any illegal
income. It is most probable that such income will remain unregistered.
As many as 3 140 people were registered as not having a stable housing situation during the last
four weeks prior to the start of treatment. However, there is reason to believe that many of them
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have stayed in hostels or institutions, although more than 1 400 were registered as homeless when
hostels, institutions and staying with others were included.  
Almost two per cent of women admitted to the measures were registered as pregnant. These
amounted to a total of 130 admissions in 2006. Questions about pregnancy were not registered in
460 admissions.
In 1 996 cases, the patients/clients stated that they lived together with children under the age of 18. 
Table 8 shows the proportion of admissions in which the patient/client was a foreign national or of
foreign descent. This applied to a greater proportion of the admissions in the Oslo region than in
the rest of the country. The gender distribution in Oslo was the same as in the rest of the country.
Table 8. The proportion of admissions in which the patient/ client was a foreign national/ of foreign descent,
2006, as a percentage.
Norway Oslo
Foreign national 2 % 4 %
Born outside Norway 4 % 9 %
Mother born outside Norway 4 % 9 %
Father born outside Norway 6 % 11 %
Source: The Bergen Clinics Foundation 
Most used intoxicant
Among women, the proportion reporting alcohol as the most used intoxicant has previously been
roughly as big as the proportion reporting heroin, while in the years 2004, 2005 and 2006, the pro-
portion of women who reported alcohol as the most used intoxicant was greater (39, 42 and 39%,
respectively) than the proportion who reported heroin (30, 26 and 26%, respectively). Among men,
alcohol was reported as the most used intoxicant by 47 per cent in 2006, while 22 per cent report-
ed heroin. The corresponding figures in 2004 were 46 and 28 per cent, while in 2005 they were 50
and 23 per cent. 
A clearly larger proportion of women (13 % in 2005 and 16 % in 2006) than men (6 % in 2005
and 9 % in 2006) reported addictive prescription drugs as the most used intoxicant. This also
includes patients/clients who have become addicted to prescription drugs which they have been
given as part of normal medical treatment. Medication given in medically-assisted treatment (MAT)
should also be registered under addictive medicinal drugs, but in practice they are probably regis-
tered as often under “Heroin and other opiates”. The increase in registrations of addictive medici-
nal drugs may be due as much to a more correct registration practice as to an increase in
MATpatients. 
“No” intoxicants applies to a small number of patients/clients who state that they have not taken
drugs or alcohol during the last six months, but who attend treatment/intervention measures to
avoid a relapse.
Figure 13 shows the most used intoxicant in 2006 and a percentage comparison between women
and men.  
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Figure. 13 Most used intoxicant 2006. Percentage.
Source: The Bergen Clinics Foundation 
Apart from alcohol, which clearly predominates (44 %), heroin is most often reported (24 %), fol-
lowed by addictive medicinal drugs (11 %) and central stimulants (10 %). Only 9 per cent report
cannabis as the most used substance. The gender difference is biggest as regards alcohol and addic-
tive medicinal drugs. In the mapping form, cocaine is part of the central stimulants category, so that
it is not possible to state a share for cocaine on its own. Together with, among other things, LSD,
ecstasy is categorised under “other”. Ecstasy was cited as the most used substance in 21 cases in
2006.  
The use of one intoxicant alone was reported in around a third of the admissions. A check of the
data basis from individual measures shows that this applies overwhelmingly to persons who cite
alcohol and much less to those who cite addictive prescription drugs as the most used substance. 
At more than 30 per cent, addictive medicinal drugs were “the second most used substance” in the
biggest proportion of admissions in 2006 as well, followed by cannabis (21 %) and central stimu-
lants (16 %). This is the same picture as in the years since 2001. Alcohol and heroin are less often
reported as being the second most used substance, at 8 and 6 per cent respectively. 
Daily (or almost daily) injecting was most common among the majority of the 32 per cent who stat-
ed that they were injecting  users. Here, it is important to remember that the data basis includes
problems users of both alcohol and drugs. There was a slight difference between those who attend-
ed treatment and care measures in the Oslo region and in the rest of the country. In the Oslo region,
clients had injected in 36 per cent of admissions (38 % in 2004 and 29 % in 2005), while the cor-
responding percentage for the rest of the country was 24 per cent (26 % in 2004 and 2005).
(Iversen et al., 2007). 
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4.2.2 Clients in medically-assisted treatment - MAT  
The data from the regional centres (14) in the Norwegian programme for MAT are included in the
client mapping survey discussed in chapter 4.2.1. The probability of duplicate registration is small in
this context because MAT patients largely remain within one treatment system. It may nonetheless
occur in exceptional cases that the same patient is registered at several regional centres in the same
year.   
At the end of 2006, there were 4 166 patients receiving MAT, an increase of 15 per cent since 2005
(3 614). Four hundred and ten patients had discontinued treatment for one or several reasons dur-
ing the year. The total number who were or had been in treatment in 2006 was therefore 4 576.
The average age was 39.9 years and the proportion of women was 30.5 per cent. Both the average
age and the gender distribution have been fairly similar during the last three years. Since the use of
and addiction to heroin is the central problem targeted by MAT, opiates naturally dominate the sub-
stance profile on admission (SKR report 1/2007).
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5. Drug-related treatment 
5.1 Treatment systems 
Changes in the treatment systems were discussed in NR 2004 and 2005, chapter 5.1.  
Summary: The regional health authorities took over responsibility for the treatment of problem drug
and alcohol users from 1 January 2004. This includes measures for which the county authorities
were previously responsible pursuant to the Social Services Act. The municipalities will still have
responsibility for coordinating the services and for measures at municipal level. The goal of the
Administrative Alcohol and Drugs Treatment Reform was to ensure good health treatment services
for problem drug and alcohol users. It was particularly important to ensure better services for
patients with compound needs for drug and/or alcohol treatment as regards psychiatric and somat-
ic health services. In relation to the provision of services and treatment results, quality is a key con-
cept and goal. The Norwegian parliament, the Storting, has stipulated certain criteria for good qual-
ity in these services: an interdisciplinary approach, a holistic approach and individually-adapted treat-
ment.
5.1.1 Evaluation of the Administrative Alcohol and Drugs Treatment Reform 
In connection with its consideration of the reform, the Storting decided that the reform should be
evaluated by the end of 2006. The purpose of the evaluation was to acquire knowledge about how
the reform was working after having been in effect for three years. The International Research
Institute of Stavanger was assigned the task of evaluating the reform. Its report was published in
January 2007 (Report IRIS – 2006/227). 
Summary of the evaluation
Increased resources 
On implementation of the Administrative Alcohol and Drugs Treatment Reform, the regional health
authorities were allocated EUR 175 million12 (NOK 1.4 billion) to cover the costs they incurred as a
result of taking over responsibility for interdisciplinary specialist services for problem drug and alco-
hol users. In addition, the health authorities have increased their budgets for the same services by
approx. 40 per cent during the period 2004-2006 (nominal growth).
The increased use of resources has been aimed at increasing health staff levels and 
assessment and treatment capacity. The service in connection with enforced treatment has been
improved somewhat. There has not been any move from long-term to short-term treatment or from
in-patient to outpatient treatment, rather the opposite. Several of the regional health authorities
devote a lot of resources to guest patient placements with the negative consequences this may have
in terms of long distances between the treatment service and follow-up on the part of the home
municipality.
12 Conversion rate: EUR 1 = NOK 8.00.
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Increase in the number of places and man-years in alcohol and drug treatment measures
After the introduction of the reform in 2004 and up until 2006, the number of places in in-patient
treatment increased by eight per cent, but the increase is unevenly distributed between the treat-
ment facilities. There has been growth in the number of man-years in in-patient facilities and out-
patient clinics. Calculations show a total increase of approximately 280 man-years in drug and alco-
hol psychiatric outpatient clinics and in drug and alcohol facilities, divided between 225 health pro-
fessionals and 55 social work professionals and educational staff.
Individual plans
There has been a clear increase in the use of individual plans in the specialist health services (NR
2005 chapter 5.1). Information from the patient survey shows that it is not until the patient com-
mences treatment in the specialist health service that an initiative is taken to establish an individual
plan. 
Little change in municipal responsibility for problem drug and alcohol users
The Administrative Alcohol and Drugs Treatment Reform has given the specialist health service con-
siderable responsibility for problem drug and alcohol users, and the state finances the patients’ stays
in drug and alcohol treatment facilities. One conceivable development of this was that the munici-
palities would take less responsibility for drug and alcohol clients than previously. Information from
social security offices does not indicate that this is the case. Slightly more than half of the social secu-
rity offices reply that there has been no change in responsibility, while a third reply that responsibil-
ity has increased in certain areas.
Poorer service in relation to demand
In 2006, fewer patients had their needs met in terms of examination and treatment at a somatic
hospital. This uncovered need for examinations increased by 14 per cent from 2003 to 2006.
Uncovered needs for treatment at a somatic hospital have increased by 10 per cent. 
Fewer clients have their needs met in terms of activation/ day centres. Uncovered needs increased
from 55 per cent in 2003 to 63 per cent in 2006.
More clients have their needs met in terms of low-threshold services in municipalities. In 2003, 43
per cent had uncovered needs for such services, compared with 31 per cent in 2006.
Fewer clients have their needs met in terms of psychiatric youth teams. In 2003, 27 per cent had
uncovered needs for such services, compared with 18 per cent in 2006.
Fewer clients have their needs met in terms of outpatient services. Uncovered needs increased from
10 per cent in 2003 to 18 per cent in 2006.
Has the reform been a success?
The answer to this question will depend on the expectations one had of the reform. If one’s expec-
tation was that the Administrative Alcohol and Drugs Treatment Reform would be an administrative
reform whereby the treatment facilities for problem alcohol and drug users were to be adapted to
and subjected to the same legislative requirements as the rest of the specialist health service, then
it is reasonable to conclude that the reform has been a success.
If one’s expectation was that the reform would lead to the same coverage of treatment needs and
the same staffing factor in the interdisciplinary specialist health service for problem drug and alco-
hol users as in the rest of the specialist health service, then much remains to be done.
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In the preparatory works to the reform, the emphasis was on the services being interdisciplinary, on
their being based on a holistic approach and on individually adapted treatment. The greater num-
ber of health professionals means the services have become more interdisciplinary. It is more in
doubt whether the reform has resulted in a more holistic (coherent) and individually adapted serv-
ice.
So far, the implementation of the Administrative Alcohol and Drugs Treatment Reform appears to
have led to a more fragmented and rigid service, with many interruptions to courses of treatment
and less individually adapted treatment as a result. The biggest challenge facing the interdisciplinary
specialised services for problem drug and alcohol users is thus to develop cooperation models and
forms of practice that satisfy professional requirements for coherent and adopted treatment rather
than focusing one-sidedly on formal referral procedures and compliance with deadlines (Report IRIS
- 2006/227). 
5.2 Drug-free treatment 
The evaluation of the Administrative Alcohol and Drugs Treatment Reform is described in chapter
5.1.1. No major new evaluations or studies of treatment services were conducted in 2006.
5.3 Medically-assisted treatment (MAT)
See chapter 4.2.2 for data about the number of patients etc. in the MAT programme. 
A study: Abstinence-orientated buprenorphine replacement therapy for young adults
in outpatient counselling
This study (Kornør et al, 2006) assessed treatment retention, compliance and completion of a 9-
month buprenorphine replacement programme. In addition, changes in drug use and other relevant
variables, as well as predictors of completion, were examined. Seventy-five opioid-dependent out-
patients (mean age 26 years; 33% females) who aimed for opioid abstinence were enrolled into the
study. Assessments were undertaken prior to buprenorphine induction and again after 3,6 and 9
months. 
40 (53%) completed the buprenorphine programme. At 9 months, 67 patients (87%) were still in
counselling. Mean attendance rates for buprenorphine dosing and counselling sessions were 0.91
and 0.74, respectively. There were significant and persistent reductions in drug use during treatment
with, however, a reversed tendency in the ninth month. Psychiatric problems escalated at 9 months,
and three patients died during the detoxification phase. Completion was predicted by fewer previ-
ous treatment episodes. Detoxification from buprenorphine is associated with substantial psycho-
logical distress and an increased death risk. Buprenorphine replacement therapy should be contin-
ued until the patient chooses to leave, and close monitoring during the detoxification phase is essen-
tial (Kornør et al, 2006). 
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6. Health Correlates and Consequences
6.1 Drug-related deaths and mortality among drug users 
See the data in Standard tables 05/06.
Methodological considerations
In Norway, there are two bodies that register drug deaths, Statistics Norway and the National Crime
Investigation Service (Kripos) Kripos bases its figures on reports from the police districts, while
Statistics Norway prepares figures on the basis of medical examiners’ post-mortem examination
reports and death certificates in accordance with the WHO’s ICD 10 codes.   
With effect from 1996, Statistics Norway’s figures have been based on EMCDDA’s definition of drug
deaths. This widened the inclusion criterion which had been used until then. In the period after
1996, Statistics Norway’s figures have been consistently higher than the figures from Kripos.
However, if we exclude suicide (in which drugs were used) and drug deaths among the elderly from
Statistics Norway’s figures, the difference is almost non-existent. The trends are largely identical in
both series of figures.
Situation and development 
According to Kripos statistics for 2006, 195 persons died as a result of drug use, 152 men and 43
women (Table 9). The figure has remained relatively stable since the peak years of 2000 and 2001.
The decline since the turn of the millennium is most probably due to the strong increase in the num-
ber of clients in medically-assisted treatment. Twenty-two of 27 police districts registered drug-relat-
ed deaths in 2006, the same geographical distribution as in 2005. Oslo had most deaths, 72, which
corresponds to 37 per cent. Very many of the deaths are believed to be due to extensive multiple
use. The 2006 figures from Statistics Norway are not yet available.
E M C D D A  –  N A T I O N A L  R E P O R T  2 0 0 7
44
Table 9. Drug-related deaths 1991-2006. Total number of deaths and deaths broken down by gender. Figures
from Kripos and Statistics Norway (underlying cause of death).
1991-2006 Number of deaths according to Kripos Number of deaths according 
to Statistics Norway
Men Women Total Men Women Total
1991 74 22 96 66 22 88
1992 78 19 97 81 23 104
1993 77 18 95 76 17 93
1994 102 22 124 105 19 124
1995 108 24 132 114 29 143
1996* 159 26 185 173 31 204
1997 149 28 177 160 34 194
1998 226 44 270 228 54 282
1999 181 39 220 191 65 256
2000 264 63 327 302 72 374
2001 286 52 338 327 78 405
2002 166 44 210 240 67 307
2003 134 38 172 174 49 223
2004 168 55 223 171 60 231
2005 146 38 184 142 48 190
2006 152 43 195 ** ** **
Source:  Kripos and Statistics Norway. 
*The figures from 1996 onwards have been classified in accordance with a new revision. Hence the figures
before and after 1996 are not directly comparable. Suicides in which narcotic substances were used are includ-
ed from 1996.
** Figures for 2006 are not yet available.
The statistics from Kripos also show that 72 per cent of the deceased in 2006 were under the age
of 40, while just over 20 per cent were under the age of 25. The percentage of drug-related deaths
among the youngest group (15-25 years) has remained relatively stable, although disturbingly high,
since the turn of the millennium. The percentage in 1999 was less than 14 per cent, in 1995 15 per
cent. One possible explanation is that medically-assisted treatment does not include the youngest
group since the lower formal age limit for admission to the programme is 25 years. 
6.2  Drug-related infectious diseases
See the data in Standard table 09.
6.2.1 HIV and AIDS
In 2006, 276 cases of HIV infection were reported to the Norwegian Notification System for
Infectious Diseases (MSIS) (Table 10). Only seven of these cases were among injecting  drug users,
all of them men and with an average age of 36 years (23-53). Five of the drug users had been infect-
ed in Oslo. The number of HIV-cases remains relatively low, and little new infection is detected in
this group.
As of 31 December 2006, a total of 528 persons had been diagnosed as HIV positive with injecting
use as a risk factor. This amounts to 15 per cent of all reported cases of HIV since 1984.
Development into AIDS has been reported in 152 of the cases. 
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Table 10. Percentage of injecting  drug users among persons infected by HIV and AIDS, with injecting risk
behaviour, by year of diagnosis.
HIV HIV injecting Percentage HIV AIDS AIDS Percentage 
Total drug use injecting drug Total Injecting drug AIDS injecting
use use drug use
1984-89 894 315 35 % 144 8 6 %
1990 90 22 24 % 59 13 22 %
1991 142 16 11% 59 16 27 %
1992 105 12 11% 50 8 16 %
1993 113 13 12 % 64 13 20 %
1994 94 12 13 % 74 19 26 %
1995 105 11 10 % 67 8 12 %
1996 116 9 8 % 56 12 21 %
1997 113 11 10 % 34 8 24 %
1998 98 8 8 % 39 5 15 %
1999 147 12 7 % 29 7 24 %
2000 176 7 4 % 38 6 16 %
2001 158 8 5 % 27 5 18 %
2002 205 16 8 % 33 3 9 %
2003 238 13 5 % 43 7 16 %
2004 252 15 6 % 34 4 12 %
2005 219 20 9 % 32 4 13 %
2006 276 7 3% 32 4 13 %
Total 3539 528 15 % 930 152 16 %
Source: Norwegian Institute of Public Health 
The incidence of HIV among injecting  drug users in the group has remained at a stable low level
over the last decade with about 10-15 cases of HIV infection a year. The reason for this is not entire-
ly clear, but a high level of testing, great candour regarding HIV-status within the user milieus, com-
bined with a strong fear of being infected and self-imposed rules in the milieu, are assumed to be
important factors. In addition, many of the sources of infection in the milieu have disappeared due
to overdose deaths or been rehabilitated through substitution therapy or other forms of rehabilita-
tion. However, the extensive outbreaks of hepatitis A and B in recent years, and the high incidence
of hepatitis C, show that there is still extensive needle sharing. The HIV situation is therefore still
unpredictable.
6.2.2 Hepatitis
During the nationwide outbreak of hepatitis A from 1996 to 2000, 1 360 injecting drug users were
identified as having acute hepatitis A. Since then, only sporadic, individual cases of hepatitis A have
been reported among injecting drug users. Since 1996, there has also been a considerable increase
in hepatitis B among injecting drug users. In 2006, 74 of a total of 149 reported cases of acute hep-
atitis B were among injecting drug users. During the period 1995-2006, the total number of report-
ed cases of acute hepatitis B among injecting  drug users was 1 812. 
In recent years, in connection with needle distribution in Oslo, small-scale prevalence surveys have
been carried out to register the incidence of, for example, hepatitis among injecting drug users. The
2006 survey showed that 71 per cent of the 231 persons included in the survey had experienced a
hepatitis A infection or been vaccinated against the disease, 43 per cent had had a hepatitis B infec-
tion and 59 per cent had experienced a hepatitis C infection. 47 per cent had tags indicating that
they had been vaccinated against hepatitis B. In Norway, hepatitis C is not monitored to the same
E M C D D A  –  N A T I O N A L  R E P O R T  2 0 0 7
46
extent as hepatitis A and B, and the number of new cases of drug users being infected with the hep-
atitis C virus is therefore not known. These Oslo surveys are the only prevalence surveys that are car-
ried out regularly among drug users in Norway. 
6.3 Psychiatric co-morbidity (dual diagnosis)
6.3.1 Mapping of patients in the psychiatric health service with concurrent problem
drug and alcohol use 
A new report, which Sintef Health Research (Sintef report A1159, 2007) has produced on assign-
ment for the Directorate for Health and Social Affairs, mapped this patient group on the basis of
information about all in-patients in Norwegian adult psychiatric institutions on 20 November 2003,
and all outpatients at Norwegian adult psychiatric outpatient clinics in two weeks in September
2004. The report is based on existing reports and data sources about the extent and characteristics
of patients with mental health problems and concurrent drug and/or alcohol problems. 
The report concludes that far more patients in the psychiatric health service than those who have
been diagnosed as having drug and or alcohol problems report problem drug and/or alcohol use. It
is difficult to find reliable methods to identify those patients who have a mental health problem in
addition to problem drug and/or alcohol use. 
Patients with a mental health problem and problem drug and/or alcohol use have compound diffi-
culties and they are often treated in different systems. Since the Administrative Alcohol and Drugs
Treatment Reform entered into force in 2004, there has been a pressing need to map the status of
this patient group before the reform is fully implemented in the health authorities in order to obtain
a basis for following developments and drawing up guidelines for the field. The report describes two
approaches to identifying the patient group: 
• Those who have been diagnosed with a drug and/or alcohol problem (Drug related problems
F10 – F19 in ICD-10) 
• Information about drug and alcohol use in the weeks prior to the start of treatment
The report shows that only 10 per cent of the in-patients examined and 13 per cent of the patients
at outpatient clinics have a drug and/or alcohol diagnosis. When a drugs and/or alcohol diagnosis is
combined with information about the patient’s problem use of drugs and/or alcohol during the last
weeks prior to the start of treatment, it is found that 25 per cent of the patients in outpatient treat-
ment and 26 per cent in adult psychiatric institutions have concurrent problem use of drugs and/or
alcohol and mental health problems. The report also states that the number of patients with prob-
lem drug and/or alcohol use is probably even greater than is registered in the mapping carried out
in connection with this report. 
The report also shows how patients with both mental health problems and problem drug and/or
alcohol use differ from the other patients in the mental health service. Those with both drug and/or
alcohol problems and a mental health problem are younger. They are more often treated in acute
wards and have shorter admissions than those with mental health problems alone. The patient
group with average/major problem use of drugs and/or alcohol who have not been diagnosed as
having a drug and/or alcohol problem have a great deal in common with those who have been diag-
nosed as having a drug and/or alcohol problem. 
The researchers behind the report propose measures to delimit and identify this patient group in as
expedient a manner as possible, and these measures will be employed in the efforts to ensure uniform
use of procedures and definitions in reporting from the drugs and alcohol and mental health fields.  
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7. Responses to health correlates and consequences
Low threshold health services, including the injection room in Oslo, were discussed in NR 2006 chap-
ter 7.1. 
7.1 Prevention of overdoses in Oslo
The number of overdoses in Oslo in 2006 increased in relation to the year before. 72 persons died
in 2006, and 56 in 2005 (Kripos figures). It is presumed that the reason may be easy access to drugs
and the fact that the overdoses with fatal outcomes take place indoors and not on the street, where
help can be given more quickly. The municipal and private services are not very successful in moti-
vating and passing on problem users to long-term treatment or rehabilitation. Users often go
straight back to the drug milieu after contact with the ambulance service and outreach service after
overdoses.
Clinic Motivation (Klinikk Motivasjon)
As part of the efforts to reduce the number of overdoses/overdose fatalities, the Alcohol and Drug
Addiction Service in Oslo opened Clinic Motivation in August 2006, a service for those at risk of over-
dosing and users who use heroin extensively and have little stable contact with the help services.
Clinic motivation is organised with outpatient activity and has 10 bedrooms at its disposal in a ded-
icated section of a lodging house. 
The clinic is a service for heroin addicts in Oslo who have little or highly irregular contact with the
municipal help services and the social services in the city wards. They are in regular contact with the
field health care stations and the needle distribution service, they live as vagabonds and use the
acute places and the winter services offered by the institutions and are sought out in connection
with overdose problems.
The goal of Clinic Motivation is to follow up these users and help and motivate them to enter the
ordinary treatment system. Field health care services, outreach services, the ambulance service and
in-patient institutions with acute in-patient places pass on users to Clinic Motivation. The users
belong to Oslo and cannot be registered as participants in medically-assisted treatment in Oslo. They
are given Subutex as outpatients and the medication is increased under supervision. If the user wish-
es a place in the institution and is allocated one during the course of the first three months, the
increase in medication will continue until the normal dose is reached.
The institution provides care, and the stay there is intended to be an active one and not just a place
to stay. Work on finding a place in the specialist health service starts soon as possible. After three
months, a decision will be made on whether medication will continue. If the medication is to con-
tinue for a further three months, a responsible team will be appointed. The user’s independent liv-
ing skills and future housing situation will be assessed. It must be clarified whether the user is moti-
vated for prolonged medication-free treatment in an institution or whether the user wishes to apply
for medically-assisted treatment. In exceptional cases, medication can be given for a further three
months to users who are clearly motivated and who are waiting for medication-free treatment in an
institution or the start up of medically-assisted treatment.
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The clinic project is funded by state funds, and it will be evaluated by an external body
(www.rme.oslo.kommune.no).
7.2 Interventions related to psychiatric co-morbidity   
Guidelines for serious mental health problems and drug and alcohol-related prob-
lems
The Directorate for Health and Social Affairs has started work on drawing up national professional
guidelines for studying, treating and following up patients with drug and alcohol problems and con-
current mental health problems.
The guidelines will deal with three main areas: 
• Knowledge about concurrent serious mental health problems and drug addiction/alcoholism/
problem use
• Recommended methods for examination and diagnosis 
• Recommended treatment and other follow-up 
A project group has been appointed, as has a broad-based reference group, which will help in this
important work. The plan is that the guidelines will be distributed for consultation in autumn 2008
and will be completed in February 2009. 
New treatment service
In autumn 2007, Diakonhjemmet Hospital in Oslo opened an interdisciplinary treatment unit for
patients with a dual diagnosis. The unit comprises an outpatient service and 12 in-patient places.
The goal is to intervene in crises, stabilise the situation, and facilitate and motivate the patient for
further treatment.
The service is meant for patients who it is currently difficult to provide with a satisfactory service
within existing measures. The buildings which house the service are specifically designed for opti-
mal adaptation to this group of patients.  It contains two separate units, each with room for six
patients. If more privacy is required, each unit can be divided into smaller units for two and four
patients, respectively. In addition, there is a room that has been specially designed for optimal mon-
itoring (www.dobbeldiagnose.no). 
Street hospital 
The Street Hospital is a somatic low-threshold service for problem drug and alcohol users in Oslo
that is run by the Salvation Army and fully funded by the state (see NR 2006 chapter 7.1). The
patients often have major, compound health problems that are not dealt with by the rest of the
health service, and they also have bad experiences from dealings with public services. Typical prob-
lems include: extensive chronic sores, serious infections, deep vein thrombosis and abscesses. Many
of them are also undernourished, emaciated and completely physically exhausted. In addition to
physical complaints, the vast majority of the patients suffer form mental health problems of various
kinds. 
On start-up in 2005, its capacity was 10 beds. Admission periods vary from one week to up to three
months. The Street Hospital was originally a three-year project. The Ministry of Health and Care
Services has now proposed making it permanent. In addition, it has been proposed to extend the
service by adding a separate ward for women (www.dobbeltdiagnoser.no).
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7.3. Prevention and treatment of drug-related infectious diseases 
In Norway, preventive measures aimed at protecting injecting  users against infection are based on
the following strategies:
• Cooperation between the health services in the municipality, outreach services, treatment insti-
tutions, prisons etc.
• Spreading information in drug user milieus about outbreaks, symptoms, how infection is
spread, personal protection and offering vaccination 
• Harm-reduction measures such as good access to clean needles and other user equipment and
medically-assisted treatment (e.g. methadone programmes)
• Vaccination of drug addicts against hepatitis B (and hepatitis A)
Antiviral treatment of the blood infection diseases HIV, hepatitis B and hepatitis C(HCV) is available
and free for addicts throughout the country. No data are available for how many addicts receive or
have received such treatment.  
A study: Hepatitis C treatment of opioid dependants receiving maintenance treat-
ment: results of a Norwegian pilot study.
The study (Krook et al., 2007) covers 17 HCV-infected heroin addicts. All of them were taking part
in medically-assisted treatment (MAT) and were being given maintenance treatment with
methadone or Subutex. The goal of the work was twofold. The primary goal was to examine the
effect of combination therapy using the medicines peginterferon and ribavirin, and secondarily to
examine whether such a treatment regime was feasible for the patient group. The 17 patients with
HCV genotype 3a were treated for 24 weeks. To optimise compliance, the treatment was given from
a department of infectious diseases in cooperation with a MAT centre. All injections were given in
the MAT centre and the patients were given psychosocial support. The compliance was 100 per
cent. All of them responded to the therapy and 16 (94%) were sustained responders. 
This study indicates that compliance and treatment outcome of opioid dependants on methadone
or buprenorphine maintenance after 24 weeks of HCV treatment corresponds to that for non-
dependants if extra support is given. The treatment should be undertaken in collaboration with spe-
cialists in addiction medicine, hepatology and infectious diseases (Krook et al., 2007).
In recent years, new treatment methods have been introduced that completely eradicate the hepa-
titis virus in many patients. And the combination of the two medicines used in the study is now rec-
ommended as the first choice in the treatment of hepatitis C. The Norwegian Medicines Agency,
Cochrane Library and, most recently, Clinical Evidence all make identical therapy recommendations
in this area (www.dobbeltdiagnose.no). 
7.4 Prevention and reduction of driving accidents related to drug use 
Alcohol Treatment Programme 
The Alcohol Treatment Programme was established as a trial scheme in five counties in 1996 and,
following a gradual expansion, it became a nationwide scheme in 2003. For a trial period, courts
can sentence drivers convicted of violation of the Road Traffic Act and who have an alcohol prob-
lem to a fine and suspended prison sentence including compulsory participation in the programme
instead of a fine and an unconditional prison sentence. The purpose of the programme is to com-
bat drink driving, contribute to greater safety in traffic and reduce the number of accidents. It is the
correctional service that is responsible for following up convicted persons who complete the pro-
E M C D D A  –  N A T I O N A L  R E P O R T  2 0 0 7
50
gramme. The programme consists of 20-30 hours of teaching, individual conversations, control and
mapping of treatment needs. Follow-up lasts for a year.
The number of such judgments has more than doubled since the programme became nationwide.
The Ministry of Justice and the Police now wishes to expand the alcohol treatment programme to
also include persons who drive under the influence of substances other than alcohol (Odelsting
proposition no. 31 2006-2007).
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8. Social correlates and consequences
8.1 Social exclusion
No new information available.
8.2 Drug-related crime
8.2.1 Drug offences
See the data in Standard table 11.
In 2006, 13 245 penal sanctions were registered in which a drug crime was the main violation (Table
11). At 40 per cent, drug crimes accounted for the largest proportion of the total number of penal
sanctions in 2006. The ratio has been approximately the same in recent years. Of the drug crimes,
only 1 543 resulted in a penal sanction of unconditional imprisonment. The others were given milder
sanctions such as a suspended sentence alone, community sentences, court-imposed fines and fixed
penalties.  
Table 11. Penal sanctions in criminal cases by type of crime, 2000-2006. Number. 
Year 2000 2001 2002 2003 2004 2005 2006
Total 21 444 34 962 27 513 29 380 29 529 33 307 33 103
Drug crimes 8 374 14 861 11 894 12 265 11 815 12 524 13 245
Economic crime 1 215 1 816 1 299 1 382 1 606 1 846 1 635
Other crime against 
property 6 658 9 652 7 376 8 213 8 217 9 333 8 919
Crimes of violence 3 195 5 055 4 186 4 687 4 826 5 777 5 419
Sexual crimes 356 510 429 571 570 722 723
Vandalism, crimes 715 1 170 873 867 905 1 049 1 018
Other crimes* 931 1 898 1 456 1 395 1 590 2 056 2 144
* Also includes environmental crimes.
Source: Statistics Norway.
There is reason to believe that a relatively large percentage of all crimes against property are com-
mitted by drug addicts as a means of financing their own habit. Since the crime statistics are organ-
ised on the basis of the individual offences, they do not provide information about how large a per-
centage of, for example, thefts and vandalism can be linked to drug addicts. The available crime
indicators with respect to drugs are thus limited to those crimes that are related to violation of drug
laws, i.e. the Penal Code and the Act relating to medicines. The Penal Code is applied in cases of
serious drug crime, while the Act relating to medicines is applied in cases involving the use of drugs
and possession of small quantities. Table 12 shows developments in the number of penal sanctions
for violation of drug laws and how they break down in terms of the application of law. 
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Table 12. The number of penal sanctions for violation of drug laws 1996-2004. 
Year Penal Code section 162 Medicines Act section 31-2 Total
1996 2 716 1 765 4 481
1997 2 858 1 472 4 330
1998 3 932 3 039 6 971
1999 4 648 3 525 8 173
2000 4 451 3 893 8 344
2001 7 456 7 314 14 770
2002 5 738 6 072 11 810
2003 6 310 5 874 12 184
2004 6 029 5 684 11 713
2005 6 830 5 540 12 370
2006 7 181 6 065 13 245
Source: Statistics Norway, Criminal justice statistics
8.2.3 Driving offences
The statistics relating to driving under the influence are monitored by the Division of Forensic
Toxicology and Drug Abuse at the Norwegian Institute of Public Health. The number of arrests in
2006 on suspicion of driving under the influence of alcohol and other substances shows little
change in relation to previous years. A small increase was registered in cases involving substances
other than alcohol in relation to 2005 (approx. 6 per cent), while the number of cases involving alco-
hol has remained virtually constant since the mid-1990s at approx. 5 000 – 5 500 cases per year,
based on the total number of breathalyser and blood tests (Figure 14). 
Figure 14. The number of road traffic cases received involving suspicion of alcohol/ other substances.
Source: Norwegian Institute of Public Health 
Finds of individual substances in road traffic cases
Methamphetamine accounts for the biggest change in terms of positive findings for illegal sub-
stances, from slightly less than 10 per cent positive in 2003 of the total number of cases received to
almost 20 per cent positive finds in 2006 (Figure 15). A corresponding increase was registered by
Kripos in the number of seizures of methamphetamine (chapter 10.4). Amphetamine and cannabis
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are still at the top with around 30 per cent positive findings. Here, it should be remarked that some
positive findings for amphetamine may be due to taking methamphetamine, which is partly con-
verted into amphetamine in the body. For other illegal substances (ecstasy, cocaine and heroin – reg-
istered as 6-monoacetylmorfin – 6-MAM), no significant changes were registered. 
Diazepam accounts for the biggest increase in findings of medicinal drugs, from approx. 20 per cent
positive findings in relation to the total number of cases received in 2004 to almost 35 per cent pos-
itive findings in 2006. The reduction in positive findings for flunitrazepam continued after the “peak
year” of 2002 when the drug was found in more than 40 per cent of the cases (Norwegian Institute
of Public Health). 
Figure 15. Finds of illegal drugs as a percentage of the total number of road traffic cases received.
Source: Norwegian Institute of Public Health 
8.3 Drug use in prison 
The National Institute of Public Health is also responsible at the national level for securing evidence,
analysis and interpretation of drugs, medicines and poisons in samples taken from persons for
whom the analysis results may have consequences in criminal law or corresponding consequences.
The clients are for the most part the police and prosecuting authorities, the armed forces, medical
examiners, the correctional service, social services and child welfare services, and some private com-
panies. 
The number of cases from prisons in which illegal drugs or medicinal drugs are found amounts to
approximately 24 000 per year. The number of such cases has increased somewhat in recent years.
Methamphetamine is increasing most, as in road traffic cases and in seizures made by Kripos. Figure
16 provides an overview.
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Figure 16. Drug finds in correctional service cases as a percentage of the total number of cases received.
Percentage.
Source: Norwegian Institute of Public Health 
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9. Responses to social correlates and consequences 
9.1 Social re-integration 
9.1.1  Employment 
National strategy plan for employment and mental health (2007-2012) 
The strategy plan was presented on 19 September 2007. The strategy continues and strengthens
employment-related efforts in the escalation plan for mental health (1998-2008). The Government’s
goal is to:
• Prevent exclusion from the employment market
• Ease inclusion in the employment market for persons withmental health complaints/ problems
In order to achieve this, the Government will endeavour to:
• Achieve good cooperation between the employment market and welfare administration and
the health service, other parts of public services, and with employers
• Ensure user participation and active participation by the individuals concerned
• Ensure good, relevant employment and health-oriented measures and services
• Ensure good competence about work and mental health in the workplace and in public services
• Ensure good knowledge, research and development
The work on strengthening possibilities for work and the accessibility of employment market meas-
ures for people with mental illnesses/ problems has shown that permanent and systematic efforts
are required in this field. The policy instruments in the strategy supplement existing services and
measures.
Some of those with mental illnesses/ problems also have drug and/or alcohol problems or other
problems. The strategy and the measures in the action plan therefore also include persons who have
drug and/or alcohol problems in addition to being mentally ill. The work on including/retaining per-
sons with mental illnesses in employment will thus involve more than working on the mental illness
or problem. The measures are designed on this basis, also those where this is not specified. The
same applies to inhabitants from minority language groups who may face major challenges as
regards both mental health problems and participation in employment.
People who also have drug and/or alcohol problems are already an important part of the target
group. The Norwegian Labour and Welfare Organisation (NAV) already offers a service to persons
undergoing methadone and Subutex treatment (MAT) and who require more extensive assistance
than the local NAV office can provide. The MAT service has competence in occupational rehabilita-
tion and is familiar with methadone and Subutex and drug and alcohol problems. The local NAV
office assists applicants with referrals to the MAT service. The policy instruments in the strategy sup-
plement existing services and measures aimed at this target group.
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9.2 Prevention of drug-related crime
9.2.1 Assistance with rehabilitation
It is estimated that 60 per cent of all inmates have a drug or alcohol problem on imprisonment. The
correctional service endeavours to ensure that inmates and convicted persons can be given help to
live a life without drugs and alcohol abuse and without crime. Relevant measures include: 
In August 2006, the justice and health sectors strengthened cooperation aimed at providing better
follow-up during and after the serving of sentences.  A circular from the Ministry of Justice and the
Ministry of Health and Social Affairs sets out guidelines for cooperation between municipal health
services, the specialist health service, the municipal social services and the correctional services in
relation to inmates and convicted drug addicts and alcoholics. The circular clarifies the division of
responsibility in relation to drug addicts and alcoholics. It will also strengthen the cooperation
between the services and contribute to better cooperative solutions and joint plans or agreements
at the regional or local level. 
From 1 January 2006, problem drug users who would previously have been given unconditional
prison sentences for criminal offences can be sentenced to take a rehabilitation programme. The
trial scheme for a drug programme under court control (described in NR 2005 chapter 1.1.) means
that problem drug users can be sentenced to complete a rehabilitation programme as a condition
for being given a suspended sentence. If the scheme had not been initiated, the target group would
have been given unconditional sentences. The participants receive services from the municipalities
and the specialist health services as part of an active rehabilitation arrangement. Through the trial
scheme, models are developed for inter-service cooperation between the correctional service and
the participating health authorities and municipalities. Day centres have been established in Oslo
and Bergen.  
Some inmates need treatment, training in independent living skills or work training that cannot be
given in a prison. Section 12 of the Execution of Sentences Act therefore provides that, in individ-
ual cases, convicted persons can serve their sentences in institutions that are not under the auspices
of the correctional service (discussed in NR 2006 chapter 9.2). This applies in particular to persons
with drug and/or alcohol problems. It is a clear goal that more inmates with problem drug and/or
alcohol use be transferred to rehabilitation institutions. In 2006, the Ministry of Justice and the
Police presented a proposal for consultation concerning rapid reaction, measures to reduce the
queue for the serving of sentences and improved content during the serving of sentences. A pro-
posal to increase the number of “section 12 days” was part of this consultation proposal. 
9.2.2 Alternative penal sanctions in relation to young offenders
During consideration of the general part of the new Penal Code in 2004, the Justice Committee
asked the Government to present a separate proposal to the Storting on conditions during serving
of sentences for persons who are under the age of 18 when sentenced. The goal is to facilitate a
fundamental review of how we can reduce the use of prison sentences for young people between
the ages of 15 and 18 and how the punishment can be better adapted to this group in cases where
a prison sentence is unavoidable.  
White paper no. 20 (2005-2006), Alternative straffereaksjoner overfor unge lovbrytere (Alternative
penal sanctions for young offenders) was discussed by the Storting on 18 December 2006. The
White Paper will later be followed up in the form of a concrete bill. 
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The Storting supported the Government’s proposal for: 
• A delimitation in the Penal Code that means that a person who was under the age of 18 when
an offence was committed may only be sentenced to imprisonment when this is absolutely nec-
essary. 
• A prohibition on prison sentences exceeding 8 years for these offenders.
• A prohibition on arresting and imprisoning persons under the age of 16 and a prohibition on
imprisoning persons under the age of 18 for more than one week at a time. 
• Introducing a statutory prohibition on persons under the age of 18 being subjected to full iso-
lation while on remand. 
• If imprisonment is necessary, the main rule shall be the use of a prison substitute rather than
prison when the accused is under the age of 18. It is desirable that child welfare institutions
can be used as prison substitutes to a great extent. 
• The White Paper proposes appointing a committee that can present proposals for alternative
penal sanctions for young offenders. In its considerations of proposals, the committee shall take
into account the fact that many of the young offenders who are currently in prison are from
foreign backgrounds and take account of the special needs of this group.
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10. Drug Markets
10.1 Availability 
Availability based on seizures
Several factors must be emphasised when describing any changes in availability. Seizures of illegal
substances by the police and customs authorities are an important parameter in this context.
However, the number of actual seizures and the quantities involved are affected by the internal pri-
orities of and resources available to the police and customs authorities, and by surveillance methods
and international cooperation. The statistics can therefore show significant fluctuations from one
year to the next, without this necessarily meaning that corresponding changes have occurred in
terms of actual availability. It is therefore a matter for debate to what extent seizure statistics are a
good tool in connection with such assessments.
On the basis of the seizures, the availability of cannabis still appears to be great. Cannabis was
seized in all the 27 police districts in 2006 as well. Twenty-one police districts have made more
seizures than in 2005, and many of them have experienced an increase of between 20 and 80 per
cent in the number of seizures compared with 2005.
In 2006, cocaine was registered in all the police districts. There are many indications that cocaine is
more widespread geographically than ever before, both in terms of absolute figures and in relation
to other drugs. The amount of unreported cases/use may be particularly large since cocaine is often
used in nightlife arenas where the police are seldom or never present. 
The number of seizures of amphetamine, and methamphetamine in particular, is clearly higher than
the level in recent years. Measured in terms of the number of seizures, these two drugs are the sec-
ond most widespread in Norway after cannabis. All the police districts made seizures of ampheta-
mine and methamphetamine in 2006, and 19 districts made more seizures than the year before.
The number of heroin seizures in 2006 was the lowest for 15 years, and the number has been more
than halved since 2001. Although the reduction is an indication that the demand for heroin has fall-
en substantially, among other things because of the number of people undergoing substitution
treatment, the reduction in recent years is nonetheless so marked that doubts can be raised about
whether the seizure statistics reflect the situation on the street with respect to availability. Kripos also
claims that it has no reason to believe that the availability of heroin has been reduced in relation to
previous years. 25 of 27 police districts made seizures in 2006. Interviews among injecting users in
Oslo conducted by SIRUS as part of the mapping of the illegal street market do not indicate that it
has become more difficult to obtain heroin in the Oslo area.  
Availability based on questionnaire surveys 
In order to measure availability, the respondents in the survey of young adults between the ages of
21 and 30 (chapter 2.2.2) were asked whether they had been offered drugs and whether they
believed that they would be able to obtain the drugs during the space of one to three days if they
so wished. 
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There has been a clear increase in the percentage who have been offered cannabis, from 48 per cent
in 1998 to 66 per cent in 2006. The increase is greatest among women. The percentage in the
nationwide sample who believe they could obtain cannabis has been stable. In the Oslo sample,
more respondents reported having been offered cannabis and being able to obtain the drug than
in the nationwide sample, but the trend was the same. There has been an increase in the propor-
tion reporting having been offered cannabis in Oslo as well, while the proportion reporting that they
could obtain the drug has remained stable.
For other drugs, it appears that the percentage who believe that they can obtain the drugs has sta-
bilised or fallen slightly. There has been a clear decline in the percentage in Norway who report that
they could obtain ecstasy, from 42 per cent in 2002 to 33 per cent in 2006. The percentage who
reported having been offered ecstasy has more than doubled, however, from ten per cent in 1998
to 23 per cent in 2002 and 24 per cent in 2006. The percentage who reported that they had been
offered amphetamine increased from 15 to 25 per cent during the same period. In the Oslo sample,
the availability of the different drugs appears to be the same as in the country as a whole.
The availability of cocaine appears to be increasing. The percentage of the nationwide sample who
have been offered cocaine has increased from seven per cent in 1998 to 15 per cent in 2002 and
21 per cent in 2006. The percentage who report that they are able to obtain cocaine also shows an
increase. In the Oslo sample, for example, this percentage increased from 35 per cent in 2002 to 40
per cent in 2006. In 1998, 16 per cent reported having been offered cocaine in Oslo. The percent-
age increased to 32 per cent in 2006 (39 % of men and 24 % of women). The observed increase
in the availability of cocaine is in line with the increase in lifetime prevalence (Lund, Skretting, 2007). 
10.2 Production, sources of supply and trafficking patterns
Most of the amphetamine and methamphetamine on the Norwegian market comes from illegal lab-
oratories in Russia, Poland and Lithuania. The customs service’s section for border controls states
that Lithuania has taken over the role of main supplier of synthetic drugs such as amphetamine,
methamphetamine and Rohypnol to Norway. Poland and the Netherlands are still important coun-
tries, but the majority of those arrested are Lithuanians.
Until last year, the main routes from Lithuania/Poland were through Germany and Denmark to the
Øresund Bridge and on through Sweden to Norway. In 2007, there has been a shift towards the
Baltic ferries, where ordinary passenger cars more or less shuttle back and forth. It is not unusual for
those who are a caught to have made many trips during a fairly short space of time. Cars prepared
with concealed cavities seems to be the most frequent method used. 
New ferry routes across the Baltic Sea: 
Klaipeda (Lithuania) – Karlshamn (Southern Sweden) and on by car to Norway 
Paldiski (west of Tallinn) – Kappelska (north of Stockholm) and to Norway
Riga-Stockholm
Tallinn-Stockholm and then to Norway
Tallinn-Helsinki – and then to Norway
As before, cannabis mostly comes to Norway from Morocco via two main routes – Spain and Italy
up to the Netherlands/Germany and on to Denmark and Norway. 
Heroin comes from Pakistan and Afghanistan via two northerly routes via Bulgaria/Romania – the
Ukraine/Russia, and then to Poland /Lithuania. Two southerly routes go through Greece/the Balkans
to the Netherlands/Germany.
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As before, cocaine comes from South America to Spain and from there to the Netherlands and
Germany before continuing up through Denmark to Norway(The custom service, personal commu-
nication). 
10.2.1 Players in the heroin trade 
SIRUS has conducted a qualitative study with the chief goal of describing the players involved in the
heroin trade and the tasks they perform (Snertingdal, 2007). The study is based on 26 qualitative
interviews with heroin dealers and importers. Of the interviews, 24 are with convicted felons serv-
ing sentences for heroin offences and two with heroin dealers who were interviewed outside prison.
The sample consists of five women and 21 men. Thirteen of the informants are Norwegian and 13
are of other ethnic origin. In addition, five police officers who have followed developments in the
heroin trade over time were interviewed.
How are players recruited?
The heroin dealers, whether they act as couriers, recipients or store the heroin, say that they are
either recruited by close friends and family (strong ties) or by more chance acquaintances (weak ties).
The stories about recruitment via strong ties point in the direction of heroin being imported through
established and long-term relations in which kinship and friendship are access criteria and constitute
a recruitment potential. The police officers believe that heroin importation is often run by various
ethnic groups with hierarchic family structures. The leader (often the father) is usually also located
abroad. Recruitment to heroin importation therefore takes place via ties of marriage and kinship.
The police informants state that, since the year 2000, collaboration across ethnic groups has
become more common in the heroin trade, but they maintain that the hierarchic family structure is
important in heroin importation.
In addition to recruitment through strong ties and weak ties, the convicted felons state that they
have performed jobs in connection with the sale of other drugs before and at the same time as hero-
in. As these informants tell their stories, the path to dealing in heroin goes via other types of drugs.
In this context, they point in particular to hash and amphetamine. This interweaves the heroin trade
with sales on a larger drug market and points towards there being flexibility in terms of tasks with-
in this larger drugs market.
How are contacts made in the milieu?
Several of the convicted felons state that the importation of heroin is controlled from abroad and
that the people who are caught in Norway are not the ringleaders. Moreover, the convicted felons
say that the power of the ringleaders over the family, both in the country of origin and in Norway,
is very strong. The police informants also state that contacts in heroin importation are made via ties
of kinship, and that these ties of kinship bind the Norwegian heroin trade to the international hero-
in trade.
None of the dealers in this material claim that they have been controlled by their suppliers. On the
one hand, it is reasonable to assume that the dealers are relatively free in relation to their suppliers
in that they can choose who they wish to deal with. Several of the dealers claim that there are many
suppliers to choose from. Both the availability of heroin and the current low prices support this
claim. On the other hand, the dealers may become subordinate to their suppliers if a situation aris-
es where they owe them money. The police informants support the claim that the heroin dealers are
free in their choice of suppliers, but they also say that some heroin dealers who are not ethnic
Norwegians are subordinate to family members who are their regular suppliers.
Both the police and the convicted felons claim that dealers no longer travel abroad themselves in
order to bring back heroin for sale. The main argument is that “sole proprietorships” have been
beaten in terms of price by other players who can import larger consignments. If it is the case that
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sole proprietorships are a historical phenomenon in the Norwegian heroin trade, this may indicate
that things are more specialised and organised further up the ladder in heroin trade than is the case
in other types of drug dealing, while sales levels are characterised by flexibility between the posi-
tions. The police confirm the convicted felons’ stories and also emphasise that players move
between different roles relating to heroin sales, but they focused less on the individuals’ drug and
dealing careers (Snertingdal, 2007).
10.3 Seizures 
10.3.1 Main features
In 2006, a total of 26 264 drug seizures were registered. This is the highest number of cases and
seizures for four years. However, there are big differences between the different drugs. 
The number of seizures of cannabis and cocaine is the highest ever. 
A record amount of amphetamine was seized in 2006. For methamphetamine, the trend is still mov-
ing steeply upwards. The number of seizures has almost tripled since 2001. Norway is probably one
of the biggest markets for methamphetamine in Europe, with respect to both the amounts seized
and the number of seizures.
In 2006, large amounts of heroin were seized, largely because of one single big seizure. In terms of
the number of seizures, there were fewer than in previous years, and there has been a steady reduc-
tion since the year 2000. 
For benzodiazepines (BZD), both the number of seizures and the amount seized show that this
group of drugs is on the increase. More than a million BZD tablets were seized in 2006. The num-
ber of tablets seized was only higher in 2002. Most of the seizures stem from illegal importation into
Norway. The abuse of prescription drugs is still at a marginal level (Kripos, 2007). 
Tendencies during the first six months of 2007
Large amounts of amphetamine and methamphetamine were seized during the first six months of
2007. The total amount of seizures is markedly greater than in any previous six-month period. Taken
together, the amount of these two drugs seized is greater than for cannabis for the first time. The
number of seizures, on the other hand, has declined somewhat. 
For cocaine, both the number of seizures and the amount seized are record high. 
On the other hand, very little heroin has been seized so far, and the number of seizures continues
to fall. The figures for the first six months of 2007 are comparable with the seizure situation in the
1980s. The number of seizures of cannabis has fallen by 15 per cent. The most striking development
is the relatively small amounts of hash seized. This not only applies in relation to last year, when the
amount was four times greater, but also in relation to the amounts that have been usual in previ-
ous years (Kripos, 2007).
10.3.2 Seizures and purity of different types of drugs
See the data in Standard tables 13, 14 and 15.
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Table 13. The number of seizures during the period 2001-2006 by the most discussed types of drugs*.
Drug type 2001 2002 2003 2004 2005 2006 % change % change
2005-2006 2001-2006
Cannabis 10 838 10 921 10 397 10 066 10 128 11 221 +10,8 % + 3,5 %
Amphetamine 4 283 5 037 4 578 4 149 4 410 4 680 +6,1 % +9,2 %
Methamphetamine 392 696 640 830 950 1 139 +19,9 % +190,6 %
Heroin 2 501 1 906 1 709 1 390 1 151 1 087 -5,9 % -130,1 %
Benzodiazepines 6 006 8 058 4 700 4 393 3 928 4 552 +15,9 % -31,9 %
Painkillers/ opioids 1 109 1 237 1 216 1 179 1 319 1 161 -13,6 % +4,7 %
Cocaine 496 577 504 489 685 726 +6 % +46,4 %
Ecstasy 837 693 405 456 341 411 +20,5 % -103,6 %
Khat 198 238 249 305 210 220 +4,8 % +11,1 %
LSD 52 15 31 31 34 28 -21,4 % -85,7 %
GHB 81 75 120 28 46 65 +41,3 % -24,6 %
Opium 21 14 7 18 16 23 +43,8 % +9,5 %
Psilocybe mushrooms 59 66 89 77 75 82 +9,3 % +39 %
Source: Kripos
*The figures have been adjusted as of September 2007. 
Figure 17. Market share for the different drugs in 2006. Percentage. 
Source: Kripos
Cannabis
A total of 1 542 kg was seized in 2006. Considerably more has been seized in some years, for exam-
ple in 2003 (2 292 kg). On the other hand, cannabis is seized more frequently than ever before. A
total of 11 221 seizures of cannabis were made in 2006. 
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Table 14. Individual seizures of cannabis above 70 kg in 2006.
Police district Amount
Oslo 224 kg
Oslo 195 kg
Østfold 94 kg
Oslo 70 kg
Romerike 94 kg
Source: Kripos
For hash – which dominates the Norwegian market – the average THC purity is roughly seven per
cent, as it has been for many years. 
Heroin
Ninety-three kilos of heroin were seized in 2006. Larger amounts of heroin have only been seized in
one previous year (129 kg in 2004). The number of seizures (1 087), however, continues to fall, and
heroin now only accounts for just over four per cent of the total number of drug seizures in Norway.
By comparison, heroin accounted for 20 per cent of the total number of drug seizures in 1998.
Twenty-five of 27 police districts made seizures. Almost half of the total amount seized was seized
in Nord-Trøndelag police district (44.93 kg). The drugs were found in an uncollected suitcase at
Værnes Airport. It is the biggest single seizure of heroin ever made in Norway. The drugs consisted
of two main types: 10.84 kg heroin chloride (purity 63 %) and 34.1 kg heroin base (purity 26-31 %). 
Table 15. Individual seizures of heroin above 1 kg in 2006.
Police district Amount Purity
Nord-Trøndelag 44.93 kg 26-63 %
Oslo 10.94 kg 31-36 %
Østfold 9.78 kg 41 %
Oslo 6.62 kg 21 %
Østfold 1.65 kg 45 %
Source: Kripos
The average purity of heroin is 29 per cent, and this is relatively low seen in a historical perspective.
However, there is still great variation in purity from seizure to seizure. 
In 2006, paracetamol and caffeine were also found in many seizures, and intoxicating substances
such as Phenobarbital, Diazepam, Flunitrazepam and Alpazolam were found in several of the mix-
tures of drugs containing heroin. 
Amphetamine/methamphetamine
A total of 3 184 kg of amphetamine was found in 4 680 seizures and 68 kg of methamphetamine
in 1 139 seizures. In addition, 4 005 tablets containing amphetamine were seized in 23 seizures,
including 370 tablets (11 seizures) containing medicinal drugs. The proportion of amphetamine and
methamphetamine in relation to other drugs has increased since 2005 and now amounts to 22 per
cent. 
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Table 16. Individual seizures of amphetamine above 15 kg in 2006.
Police district Weight Purity
Oslo 58.8 kg 18 %
Romerike 40 kg Not analysed 
Oslo 26 kg 32-36 %
Oslo 18 kg Not analysed
Østfold 17 kg 14 %
Source: Kripos
Table 17. Individual seizures of methamphetamine above 2 kg in 2006.
Police district Weight Purity
Østfold 14.6 kg 88 %
Oslo 9.32 kg 44 %
Telemark 4.95 kg 61-67 %
Søndre Buskerud 4.72 kg 67 %
Østfold 2.76 kg 73 %
Source: Kripos
As in previous years, the purity of these drugs varies in all types of cases. The average purity was
estimated to be roughly 43 per cent for amphetamine and 55 per cent for methamphetamine.
Ecstasy
In 2006, however, 28 636 tablets were seized in 411 seizures, which is a marked increase from
2005. In relation to other drugs, ecstasy still appears to have a much smaller market share than was
the situation from 1999 to 2003. Unlike the period around the turn of the millennium, when ecsta-
sy was registered in all police districts in the country, ecstasy was only seized in 17 police districts in
2006. On the other hand, all the 17 police districts made more seizures in 2006 than the year
before. 
Table 18. The largest individual seizures of ecstasy in 2006. 
Police district Number of tablets Active agent mg per tablet
Oslo 10 300 MDMA 128 mg
Oslo 3 260 MDMA 79 mg
Sør-Trøndelag 2 800 MDMA 27 mg
Oslo 989 MDMA 47 mg
Østfold 950 MDMA 77 mg
Source: Kripos
Cocaine
Seven hundred and twenty-six seizures of cocaine were made in 2006, the highest number of
seizures of cocaine ever made in Norway. The amount seized was slightly over 40 kg, and this is
regarded as being at the normal level in relation to the preceding years. The proportion of cocaine
in relation to all other drugs has increased from 0.5 to 3 per cent in 10 years. 
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Table 19. Individual seizures of cocaine above 1.5 kg in 2006.
Police district Amount Purity
Østfold 15.64 kg 33 %
Østfold 4.5 kg 33–56 %
Oslo 2.0 kg 36–38 %
Østfold 1.66 kg 44 %
Østfold 1.64 kg 52 %
Source: Kripos
The average purity of cocaine has fallen considerably in recent years. Ten to fifteen years ago, the
purity was usually 70 per cent or more. In 2004 and 2005, it was estimated to be approx. 50 per
cent, while it was estimated to be approx. 38 per cent in 2006. The explanation for this is that sup-
pliers – probably in Europe – add substances with no intoxicating effect. 
GHB
The seizure figures for GHB and the chemically related industrial products GBL and butandiol are rel-
atively small, and the data do not indicate that the market share of these drugs is increasing. 
Table 20. Seizures of GHB, GBL and 1.4 butandiol in 2006
Drug Number of seizures Amount seized
GHB 65 18 litres
GBL 11 11 litres
1.4 butandiol 17 25 litres
Source:Kripos
Benzodiazepines (BZD) 
More than a million seized tablets in 4 552 seizures means more than a doubling of the amount and
a 16 per cent increase in the number of seizures in one year. One individual seizure accounted for
all of 498 500 Valium tablets, and that is by far the biggest seizure of BZD ever made in Norway.
Twenty-one police districts made more seizures in 2006 than the year before. 
Seizures of BZD are often made together with several other drugs, such as heroin, amphetamine and
cannabis. There were major shifts in the seizure frequency between the different BZD drugs in 2006
as well. This is primarily due to a big decline in tablets containing Flunitrazepam. The seizure fre-
quency for Diazepam exceeded that for Flunitrazepam in 2005, something that has not been regis-
tered for more than 10 years. This trend was reinforced in 2006, both in terms of the amount seized
and the number of seizures. Moreover, other types of BZD are more frequently seized than before.
This may be connected to an increase in the prescription of such alternative medicinal drugs, since
Rohypnol is now de-registered in the medical context and is thus no longer prescribed.
Painkillers, drug-classified medicinal drugs
A total of 15 685 tablets were seized in 1 161 seizures. No particularly large seizures were made in
2006. Both the number of seizures and the amounts seized were at roughly the same level as in pre-
vious years. Information received indicates that the cases increasingly concern illegal importation of
such medicinal drugs via internet shopping, while the number of tablets in each seizure is relatively
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small. It is primarily medicinal drugs containing buprenorphine, codeine, methadone and morphine
that dominate the statistics, with approx. 97 per cent of all seizures (Kripos, 2007). 
Table 21. Seizures of drug-classified medicinal drugs in 2006.
Drug Percentage of seizures Number of tablets
Buprenorphine 47 % 2 900
Codeine 25 % 8 500
Morphine 18 % 1 800
Methadone 7 % 275 tablets/units
Other 3 % 418
Source: Kripos
10.4 Prices 
See the data in Standard table 16. The estimated prices for drugs bought on the street generally
show little change in 2006.
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Part B: Selected Issues
11. Public expenditure 
The topic is limited to drugs law enforcement costs only. Some data concerning health costs are
given in chapter 1.3.
11.1 Drugs law enforcement costs in Norway 2005.
Summary
It is estimated that the direct costs of police investigation, prosecution and jail for drug offences in
Norway is EUR 234 million (NOK 1.8 billion ), which is 15 per cent of the total costs of the criminal
justice system and about EUR 51 (NOK 400) per capita.
11.1.1 Introduction
Several large studies have tried to estimate the social cost of drug use. All of them include the cost
of crime as a major component. In some it is second to “lost productivity” and “health costs”, in
others it is the main cost category. For instance, according to Harwood (1999), the cost of drug
abuse to the United States in 1992 was USD 97,6 billion, of which crime was responsible for 18.4
per cent. The main cost category was “lost earnings” which accounted for 71 per cent of the esti-
mated costs. In another study (Henley et al,1998), based on a sample of 1 075 drug users in the UK,
the conclusion was that each user cost society about $17,000 and that crime represented 78 per
cent of these costs (the rest were mainly health care costs). One of the reasons why crimes turned
out to be so costly in that study was the inclusion of the value of the goods stolen as a cost of the
crime. 
This paper gives a first approximation of how much illegal drugs cost the criminal justice system in
Norway in 2005. It takes a direct approach, focusing only on direct expenses, not on indirect costs,
victim costs, or the value of the stolen goods. This is not because these costs are believed to be
unimportant, but because information about their magnitude is very unreliable.
11.1.2 Calculating the costs: A first approximation
The state has at least three direct costs as a result of criminal activities:
1 Police expenditure (investigation etc.) 
2 Expenses relating to courts (defence lawyers, judges etc.)
3 Expenses relating to jail 
Based on the national accounts, total outlays in these three areas in 2005 in Norway amounted to
about EUR1.6 billion (NOK12 billion).The question then is how much of this we can “blame” on
drugs? 
A very simple approach would be to examine how many investigations, prosecutions and (inmates
serving) prison sentences are traceable to drug offences. Statistics Norway has the following table:
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Table 22. Percentages  of cases directly related to drugs, 2005. 
Total number  Cases directly related  Percentage 
of cases to drug use drug cases
Police investigations 399 074 40 092 10.05%
Prosecutions 88 962 19 882 22.35%
Jail inmates 3 170 912 28.77%
Source: http://www.ssb.no/vis/emner/03/05/lovbrudde/art-2007-08-13-01.html (Table 7 and 53)
We already know the total cost of all cases and we use the results from Table 22 to estimate the
costs directly related to drugs (Table 23).
Table 23. Drug law enforcement costs in Norway 2005. In EUR.
Total expenses Drugs % ‘Cost of drugs Per capita
to the state 
Police investigations 1,080,423,507 10.05% 108,542,123 24
Prosecutions 210,181,095 22.35% 46,973,096 10
Jail inmates 273,499,005 28.77% 78,684,887 17
ToTotal 1,564,103,607 14.97% 234,200,106 51
Source: National Budget 2007 (http://www.regjeringen.no/nb/dep/jd/dok/regpubl/stprp/20062007/Stprp-nr-1-
2006-2007-/1.html?id=298317) 
Note: The table only includes the cost of illegal drugs, not alcohol, and it only includes direct costs.
If one is willing to accept the rough approximations made, the figures show that the Norwegian
government spends a minimum of approx. EUR 234 million each year in connection with directly
crime-related drug control expenses. This is about EUR 51 for each taxpayer in Norway.  Compared
with other countries, this is quite high.  Single et al (1999), for instance, calculated that the total
cost of illicit drugs in Canada in 1992 was about EUR 36 per capita.
11.1.3 Drugs and property crimes: A Brief overview
One might argue that drugs are also behind a great deal of property crime, and that the cost of
property crime should therefore be included in the estimates above. This is true, but the problem is
how to estimate this accurately enough to justify a particular amount. 
It may be useful to have some factual knowledge about property crime and drug use in Norway. A
total of 195 229 property crimes were reported to the police in Norway in 2005 (this includes theft,
burglary etc.  but not “white-collar crime”).  They constituted almost 50 per cent of all crimes
reported to the police.  About 25 per cent of the convictions of current prison inmates involved
property crimes as the most serious offence, and 30 per cent involved drug crimes as the most seri-
ous offence. It is commonly believed that drug users are responsible for a large number of the prop-
erty crimes. 
In the absence of hard evidence there is good reason to question the common belief. First of all, one
could ask how many drug users really finance their habit by property crimes (and to what extent).
Secondly, even if it turns out that almost all drug users engage in property crimes, the group itself
is very small compared with the non-users. A high percentage of a small group may be a smaller
number than a small percentage of a very large group. Hence, the common inference from “all drug
addicts are thieves” to “all thieves are drug addicts” may be an example of a widespread cognitive
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mechanism that produces logically invalid conclusions. To be more certain, however, we need hard
evidence.
On the matter of the extent to which drug users finance their habit with income from property
crimes, there is some evidence to suggest that it is smaller than assumed in the view that “most or
all regular drug users are thieves.” For instance, Bretteville Jensen (1996, 2005) has conducted a
large survey of drug users and, on average, they report that between 20 per cent and 25 per cent
of their income is generated by property crimes. It should be noted, however, that the distribution
was highly skewed. A small minority of drug users committed a lot of property crimes while many
committed few or no such crimes. For instance, women were far less likely than males to engage in
crimes (but much more likely to engage in prostitution). 
Moreover, to cover “just” 20 per cent of their average expenses they would have to steal goods
worth large sums of money, since stolen goods typically only command between 10 and 30 percent
of their market value in the legal market. Similar results can be found in other surveys. For instance,
in an admittedly non-random and skewed sample of about 500 drug users in treatment, 63.5 per
cent reported that they had been prosecuted for property crimes (unpublished survey results from
the Cost-Benefit project, see NR 2003 chapter 11.2). However, “only” about 10 per cent reported
that crime (excluding the sale of drugs) was their main source of income. In short, while there is evi-
dence to suggest that many drug users  engage at some point in some crime, it seems far from true
that all drug users finance most of their expenses with income from property crimes. 
It is very difficult to collect reliable data on the relative percentages of drug users and non-drug users
among those who commit property crimes because of the illegal nature of both activities. It is pos-
sible, to some extent, to focus on the sub-group consisting of those who are caught, but this group
may not be representative of the whole group. There may, for instance, be an overrepresentation of
drug users among those who are caught because they may tend to leave more traces or because
the police tend to focus on them as a group that is easy to catch (they are already well known to
the police). 
If we choose nevertheless to focus on those who are caught, we can use data from Statistics Norway
on recidivism among different types of offenders to get some impression of the percentage of drug
users in those convicted of property crimes. The data tell us that out of the 17 168 persons con-
victed of property crimes in 2000, 9 573 (56%) were convicted again within five years, and 1 719
(10%) were reconvicted for a drug offence as the most serious charge. This is an indication that far
from all property crime convictions involve drug users. However, we should also remember that the
police seldom prosecute simple possession of drugs for own use, and when they do so it may be as
part of a larger package including a more serious offence. It is only when a drug offence is “seri-
ous” (dealing in large quantities, smuggling) that it is counted in the statistics as a drug offence.
Altogether, the evidence suggests that we should avoid making drug users the main culprits for
property crimes. This is not to say that they do not commit property crimes, only that they do so less
than is commonly believed. Moreover, the group is so small that property crimes committed by its
members may easily drown in the sea of property crimes committed by the much larger group of
“non-regular drug users.” 
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12. Vulnerable groups of young people
12.1 Vulnerability and risk factors. Definitions and delimitations 
Vulnerability is the inability to cope with external pressures and deviations, which may result in
severe harm or major loss of value. Vulnerability says something about how easily something can be
harmed or ceased to function (definition, Research Council of Norway).
Nordahl et al. (2005) define a risk factor as ”any factor in an individual or his or her childhood envi-
ronment that can be associated with increased probability of future negative psychosocial develop-
ment”. A protective factor is defined as ”any factor in an individual or his or her childhood envi-
ronment that can be associated with decreased probability of future negative psychosocial develop-
ment” (ibid). Risk factors and protective factors are not necessarily opposites; it would be more cor-
rect to say “that a protective factor is a factor that interacts with risk factors and reduces their neg-
ative impact …” (ibid.). 
It is important, however, to underline that a risk factor does not imply a linear and necessary pro-
gression from a specific exposure to risk to, for example, a serious drug and/or alcohol problem.
Young people who are not in vulnerable situations or in a defined risk group may also develop drug
and/or alcohol problems. The use of vulnerability and protection models is relevant when outlining
interventions in cases involving increased probability of developing problems, but they are not
meant to be predictors of individual fates. In short, not all young people in risk groups develop prob-
lems (ibid) and we should therefore be very careful about how we use the terms “risk factor”, “vul-
nerability” and “risk group”. They are best used exclusively in connection with interventions. 
In this chapter, the term youth is limited to persons under 25 years of age. However, most of the
data and comparisons mainly refer to the under-twenties and apply to problem drug and alcohol
use in general, often in combination with other risk factors. There is little information specifically dis-
tinguishing between the use of illegal and legal substances in a description of vulnerable groups of
children and adolescents. 
.
12.2 Profile of main vulnerable groups 
Children and adolescents
There are no good estimates at the national level of the amount of people at risk of developing drug
and/or alcohol problems. With respect to children and behavioural problems, it is estimated that one
to two per cent have a high risk and five to ten per cent a moderate risk of developing severe behav-
ioural problems (Nordahl et al. 2005).
Children/ adolescents with parents with drug, alcohol or mental health problems 
We now have solid documentation that children of parents who misuse drugs and/or alcohol are at
increased risk of developing mental health or psychosocial problems during childhood, including
problem use of drugs and/or alcohol. Several studies of problem drug users document that more
than one in two have had parents with drug and/or alcohol problems (Lauritzen et al. 1997, Melberg
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et al. 2003). There are, however, no good estimates of how many children are affected by their par-
ents’ drug, alcohol and/or mental health problems. Uncertain estimates indicate around 200 000
children. 
Children/ adolescents exposed to violence
So far, a connection has not adequately documented in Norwegian research between having been
subjected to or witnessed violence and the subsequent development of drug and/or alcohol prob-
lems. It can be observed in general that children and adolescents living in violent homes are at risk
of many things, including alcohol and/or drugs and violence. Pedersen (2006) points out that boys
are more exposed to violence than girls, and that there is strong correlation with their own alcohol
consumption. ”The typical victim of violence is a lonely boy. He has a problematic relationship with
alcohol, perceives himself as masculine and uses violence himself” (ibid.).
Up to the age of twelve, approximately one school pupil in six is exposed to bullying. Between the
ages of 13 and 17, the number is about one in ten, according to studies carried out in Norway in
the late 1990s. Children with poor sight or hearing or with other health problems are bullied more
often than healthy children. However, we have no documentation at present of any connection
between being exposed or subjected to bullying and subsequent problem use drugs and/or alcohol
(Schancke 2004 red.). 
Children/ adolescents exposed to neglect 
Almost ten per cent of all children have received help from the child welfare service before the age
of 18, with approximately one in ten of them spending a shorter or longer period in an institution
(Kristofersen 2005). Children with links to the child welfare service, and their biological parents, suf-
fer far more illness than other families and they experience major health problems. The suicide fatal-
ity rate is significantly higher in children in receipt of help from the child welfare service than in the
rest of their age group: 16 per 10 000 as against 2 per 10 000. Drugs and/or alcohol are involved
in a greater number of deaths and accidents in both the children and their parents (ibid). This is a
clear indication that problem use of drugs and alcohol is a serious problem among children receiv-
ing help from the child welfare service. 
There is no good documentation of the extent of the problem use of drugs and/or alcohol among
these children. However, experience at the local level indicates a substantial misuse of drugs nd/or
alcohol among children in child welfare institutions. We note, for example, that a large proportion
of problem drug users receiving treatment have previously been in the care of or received help from
the child welfare service. The transition from child welfare institution to adult life is a particularly dif-
ficult phase for some. SIRUS is involved in a collaborative initiative with the Norwegian Directorate
for Children, Youth and Family Affairs concerning awareness in child care institutions of early devel-
opment of problem use of drugs and/or alcohol. So far, empirical data indicate that such problem
use in child welfare institutions is poorly mapped, and that any existing mapping is unsystematic. 
School dropouts
Dropping out of school is only one of several indicators of a perturbing development, and it must
be viewed along with other behavioural patterns. We have no good estimates of the numbers of
school dropouts where the problem use of drugs and/or alcohol is a contributory factor.
Approximately five per cent of problem users embarking on treatment/care measures in the period
1999-2004 stated that they had not completed their basic compulsory schooling, in other words
they had dropped out of lower secondary school (Iversen et al. 2005). This estimate is too low, how-
ever, with respect to the total school number of dropouts as these data do not show how many
pupils dropped out at the next level, i.e. upper secondary school. 
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Children and adolescents with mental health problems
Between five and seven per cent of children and adolescents have mental health problems that
require treatment (Agledal et al. 2006). Some studies show that children with mental health prob-
lems are at greater risk of developing drug and/or alcohol problems during their youth (Agledal et
al. 2006). The incidence of drug and/or alcohol problems is significantly greater in persons with
schizophrenia, affective disorders, personality disorders, posttraumatic stress disorders and gambling
addiction (ibid). Some young people have an individual vulnerability related to ADHD, behavioural
problems etc. An estimated nine per cent of all 15-year olds in Oslo have both mental health and
drug and/or alcohol problems. As many as 39 per cent of the children and adolescents in Oslo who
have mental health problems are also problem users of alcohol (Agledal et al. 2006). 
Pedersen (2006), however, points out on the basis of his longitudinal study that anxiety and depres-
sion would seem to be weak predictors of the subsequent development of drug and/or alcohol
problems. This is partly because the group that has suffered from occasional anxiety and depression
is large and partly because such disorders are associated with introversion and caution, which both
Pedersen (2006) and Pape (1996) associate with a reduced tendency to use drugs and/or alcohol.
Children and adolescents who have developed severe behavioural problems
Some children have developed severe behavioural problems that meet the formal diagnostic criteria
in ICD-10 and DSM-IV. These are children and adolescents with what is called ”risk behaviour” such
as violence, crime, conflicting relationships with their surroundings, aggressiveness, acting-out and
the use of drugs and/or alcohol. What distinguishes this group from the previously mentioned
groups with the same risk behaviour is the severity of the behavioural disorder. Behavioural disor-
ders constitute the most common mental disorder in children and adolescents in Norway, affecting
approximately five per cent of the total child and youth population. A great preponderance of those
affected are boys, in a ratio of 3:1. 
Young people hospitalised for intoxication or other drug and/or alcohol harm
Data from the Norwegian Patient Register show that a total of 889 young people aged 15-24 were
admitted to Norwegian somatic hospitals in 2005 with alcohol intoxication as either the main or a
secondary diagnosis (Table 24). On the basis of these figures, the number of intoxications seems to
have increased greatly in the last five to six years by as much as 75 per cent in the 20-24 age group.
Nevertheless, the numbers fell from 2004 to 2005. 
Table 24. Alcohol intoxication in children and young people aged 15-24. 1999-2005.
% %
Age groups 1999 2000 2001 2002 2003 2004 2005 change change
04-05 99-05
Females 15-19 210 232 231 272 270 269 251 -6.7 19.5
Males 15-19 188 211 224 232 236 278 244 -12.2 29.8
Females 20-24 106 118 138 150 162 196 185 -5.6 74.5
Males 20-24 119 154 184 255 201 236 209 -11.4 75.6
Comment: development in number of hospital admissions with alcohol intoxication as either the main or a sec-
ondary diagnosis recorded in NPR patient data for somatic hospitals. By age group and gender. 1999-2005.
Including ICD10 codes T510, T511 and F100.
Source: Norwegian Patient Register
On the basis of the above table, there seems to be no significant gender difference. Admittedly, the
number of intoxications in 1999-2005 increased more among males aged 15-19 than in females in
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the corresponding age group, but the numbers are relatively similar. In the 20-24 age group, rather
more males than females were registered as having been admitted with intoxication as the main or
a secondary diagnosis.  
At present, professionals in the field experience that there is a lack of system in terms of registra-
tion and intervention in relation to young people admitted to casualty/ hospital departments for
alcohol intoxication or drug and/or alcohol-related injuries. Practice probably varies from hospital to
hospital. Therefore, the figures in the table above probably do not give a full and accurate picture
(Directorate for Health and Social Affairs, 2007). 
12.3 Drug use and problematic drug use in vulnerable groups
Vulnerable young people from ethnic minority backgrounds 
Young people from immigrant backgrounds are described on the one hand as being more
abstemious in some situations than ethnic Norwegian youth (Puntervold Bø et al. 2004, Amundsen
2005, Schultz 2003). This applies in particular to young people from Muslim backgrounds. Pedersen
(2006) finds few traces of ghetto development, marginalisation and use of drugs and/or alcohol
among non-western immigrants in the Oslo East district. ”On the contrary, what is striking is their
law-abiding and tradition-bound way of life. Moreover, more recent data indicate that their cautious
consumption is ‘infectious’ in relation to young people from Norwegian backgrounds.” (Ibid.) 
Nevertheless, a number of professional groups identify special problems relating to the various immi-
grant youth milieus, including gang formation and the use of drugs and/or alcohol. Persons from
immigrant backgrounds who develop drug and/or alcohol problems seem to be excluded more fre-
quently from their own environment than is the case for ethnic Norwegian youth who are starting
to misuse drugs and/or alcohol. Moshuus (2005) demonstrates the existence of a small group of
poorly integrated young immigrants, but, according to Pedersen (2006), this represents the excep-
tion rather than the rule. 
Øia (2005) shows that immigrant youth are exposed to many of the same pressures/ risk factors as
ethnic Norwegian youth. In addition, immigrant youth are at risk in connection with ethnic culture
conflicts, adaptation strategies in relation to Norwegian society and identity management. It is,
therefore, not just a matter of an individual’s ability to adapt to Norwegian culture; the tolerance
and integrative capacity of the local population are also a factor.
12.4 Vulnerable groups among the treated population 
See chapter 4.2.1.  No further information is available.
12.5 Correlates and consequences of substance use among vulnerable
groups 
Criminal behaviour
Along with traffic offences, crime against property is the most common reason why 15-20-year olds
end up in police registers. Although young people are overrepresented in the group charged with
aggravated theft, the trend throughout the 1990s has been towards fewer aggravated theft charges
and more simple theft charges among young people. The increase in recent years in the number of
people arrested for drug offences applies to most age groups, but the most striking trend is among
young people. In almost a third of the arrests of 15-20 year-olds for crimes in 2004, drugs were the
main offence.
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In May 2007, Oslo Police District and the City of Oslo launched the trend report “Barne- og ung-
domskriminaliteten i Oslo 2007 (Child and Youth Crime in Oslo 2007)”. This report was prepared as
part of a collaboration between the Oslo Police District and the City of Oslo and is the second in the
series. Its aim is to increase knowledge about crime and drug/alcohol use among children and youth
in Oslo and thereby obtain a broader picture of the current situation and trends. The report deals
with children and young people up to and including the age of 23, with the greatest emphasis on
those under 18. A new feature this year is the inclusion of crimes to which children and youth are
exposed. In addition, there is special focus on recidivist crime and the recruitment of young people
to criminal groups of troublemakers, networks and gangs.
In 2006, children and young people under 18 were responsible for 6.7 per cent of reported offences
in the Oslo Police District. The majority of these young people were only reported for one offence
during the year. It is important to note that only a small percentage are reported for multiple
offences. The most common offence for girls under 18 is petty theft, while drug offences are preva-
lent among girls in the 18-23 age group. Petty theft is the most common offence among boys under
15, while for boys in the 15-17 age group, violence and threats are most common, closely followed
by drugs. For boys in the 18-23 age group, the most common offence is drugs. 
Statistics and informants confirm that there is cause for concern about several milieus that commit
a lot of crimes together. An analysis of recidivists shows that it is the same young people who are
registered with most criminal offences in the areas of robbery, physical violence and drugs
(www.rme.oslo.kommune.no/kompetansesenteret).
12.6 Responses to drug problems among vulnerable groups
12.6.1 Policy and legal developments
The action plan Sammen mot barne- og ungdomskriminalitet (Together against child and youth crime)
(2005-2008)
This action plan (Ministry of Justice and the Police, 2006) has been drawn up in a collaboration
between six ministries. It focuses on individual young offenders under 18 years of age – both above
and below the age of criminal responsibility (Note: It is not specifically related to drug and alcohol
problems) The plan contains 21 measures intended to ensure age-adapted, responsibilising and
rapid follow-up of individual young offenders. It targets recidivists and perpetrators of serious crimes
in particular. In the case of adolescents between the ages of 15 and 18, steps will be taken to facil-
itate a customised and coordinated use of remedies within the penal justice system and in society
at large. In this age group, young people who are in prison (either on remand or serving a sentence)
represent a particular challenge. 
Alternative penal sanctions for young offenders (under 18).
The proposals in White Paper no. 20 (2005–2006) to the Storting Alternative straffereaksjoner over-
for unge lovbryterer (under 18 år) (Alternative penal sanctions for young offenders (under 18)) are
discussed in chapter 9.2.2.
12.6.2 Prevention and treatment
Early intervention 
The Directorate for Health and Social Affairs has drawn up a proposal for a national strategy for early
intervention in the area of drugs and alcohol. The report “Tidlig intervensjon på rusområdet, sen-
trale perspektiver – aktuelle målgrupper og arenaer (Early intervention in the area of drugs and alco-
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hol – relevant target groups and arenas)” was submitted to the Ministry of Health and Care Services
in December 2006. The report also deals with adults, but its main focus is on children and young
people. The strategy proposals are discussed in chapter 3. 1. 
Young people from immigrant backgrounds and early intervention in relation to drugs and alcohol
The Directorate for Health and Social affairs has commissioned the Alcohol and Drug Addiction
Service in Oslo (RKS) to lead a national project to clarify the need for early intervention in drugs and
alcohol matters in various immigrant youth groups, and to submit proposals for how such work can
be organised. The project’s main purpose is to determine the extent to which young people from
immigrant backgrounds need special measures to prevent the development of drug and/or alcohol
problems. 
Various risk and protection factors relating to the development of drug and/or alcohol problems will
be used to shed light on the matter. One of the project’s central questions is whether an ethnic iden-
tity represents a protective and/or risk factor in relation to the use of drugs and/or alcohol. RKS will
present the results of the project in a report on conclusion of the project, which is scheduled for 31
December 2007.
The treatment methods: parent management training and multisystemic therapy
The Ministry of Children and Equality has been working for a long time on the implementation of
family and community-based methods for the treatment of serious behavioural disorders.  The use
of drugs and/or alcohol is often a part of the problem complex. 
Parent Management Training (PMTO) is a treatment method targeting children aged four to twelve.
The method is intended to change intractable negative patterns. Training using this method started
in Norway in 1999. Parent management training is provided by the Directorate for Child, Youth and
Family Affairs or the mental health service for children and youth. The method is being evaluated in
Norway and the results so far are promising. Reducing behavioural problems may well have a pre-
ventive effect on the development of drug and/or alcohol problems later in life. Work is currently in
progress to implement the method in municipal services.
Multisystemic therapy (MST) is a method targeting adolescents aged 12 to 18. It involves close fol-
low-up of the adolescents concerned, their families and the local community. Treatment is provided
by the five regional child welfare and family welfare services. Training started in Norway in 1998. So
far, the evaluation results are positive. Research from the USA shows a substantial reduction in
behavioural problems, including drug and/or alcohol problems, both at home and at school. In
Norway, multisystemic teams attached to the child welfare service have been set up.
MultifunC is the name of a service currently under establishment in the child welfare service. Six
open institutions will be established targeting young people with behavioural problems who cannot
be helped through home-based measures. As of 31 July 2006, four institutions have been opened.
The young people in the target group have problems in several areas, and drug and/or alcohol may
be one of them. These young people need intensive and coordinated action on the part of the child
welfare service. The institutions will offer a limited period of residential care followed by a period of
aftercare once the young people have moved back home. Cooperation with the families and the
young people themselves will be emphasised throughout. Motivation and involvement of the fami-
lies in the decisions that are made is an important part of the treatment. Staff at the institutions will
be given thorough training in the methods to be used. Systems to evaluate the measure will be inte-
grated into the treatment through counselling and registration (Directorate for Health and Social
Affairs, 2007). 
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Measures on the part of the police
In collaboration with other public bodies and voluntary organisations, the police will carry out pre-
ventive work to limit the use of drugs. Particular weight will be attached to measures to reduce the
availability of and demand for drugs, thereby reducing recruitment to the user milieus. The preven-
tion of the problem use of drugs and/or alcohol is a central element in efforts to create good con-
ditions for children and young people to grow up in. The police work with the home and with
schools, among other things by means of their ”Bry deg” (Show that you care) initiative. The police
conduct cause-for-concern interviews with parents of children and adolescents under 18 who are
suspected of using illegal drugs (Directorate for Health and Social Affairs 2007).
Outreach work
Outreach workers (http://www.utekontaktene.no/) are particularly important in the early interven-
tion context, identifying and intervening in relation to young people who are in need of support or
help but who are not adequately picked up by other parts of the help services. Outreach teams work
with youth clubs, schools, the child welfare service, social security offices, school health services and
health stations for young people, preventive police services, young people’s families and others.
There are currently about 70 outreach units in Norway. “This means that outreach workers are in
constant contact with approximately 14 000 young people who are experiencing moderate or
severe problems in life” (president of the Norwegian national association of outreach workers -
quote). Some focus on preventive work among children and young people, others on drug addicts
and alcoholics of different ages. Outreach units have also been established to better identify emer-
gency situations, inform about/bring in available help and follow-up if there is a risk of overdosing.
These services also carry out home visits and offer transport home or to detoxification stations
(Directorate for Health and Social Affairs, 2007). 
Grant schemes
There are several grant allocation schemes targeting children and young people. Chapter 1.3 deals
with grants for specific focus areas in preventive work and measures aimed at problem drug and/or
alcohol users.  
The grant scheme “Measures among children and young people in large urban communities” tar-
gets children and young people with special needs and vulnerable groups of young people. The
scheme, which is a measure to improve the conditions in which children and youth in urban com-
munities live and grow up, includes 23 urban municipalities across the country. Young people from
immigrant backgrounds face special challenges, and high priority is given to measures to promote
their integration.
This grant scheme also has earmarked funds for measures to counteract poverty problems, in par-
ticular in the cities and areas with major living-condition problems. The grants are intended to
finance holiday and leisure activities for children, young people and their families, and measures to
improve contact with the employment market for young people with little or inadequate education.
The four largest cities - Oslo, Bergen, Trondheim and Stavanger – will be given special priority
(www.bld.dep.no).
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13. Drug related research in Norway
13.1 Research structures
Drug-related research in national policy
Norway’s policy in this field covers both drugs and alcohol. This is also reflected in research.  Drug
research is not, therefore, a separate area, but is included as part of drug and alcohol research,
which to a certain extent also covers tobacco and gambling.   
Formally, Norway does not have a functioning action plan in the drugs and alcohol field. On pres-
entation of the national budget for 2008 in October 2007, however, the Government presented an
escalation plan for the drugs and alcohol field. Research is mentioned in the escalation plan under
the objective of improving quality and raising competence in the drugs and alcohol field. The esca-
lation plan will be formally adopted when the national budget is considered by the Storting in
December 2007. The plan is discussed in more detail in Part I, chapter 1.2.1.
Research into drugs and alcohol is one of the priority areas in the escalation plan. The Government
will build on the central research milieus at the Norwegian Institute for Alcohol and Drug Research
(SIRUS) and the Norwegian Institute of Public Health. Moreover, the plan emphasises that a sepa-
rate drugs and alcohol research programme has been established under the auspices of the Research
Council of Norway, and a new centre for drug and alcohol research has been established at the
University of Oslo. The escalation plan also states that the regional health authorities (which are
responsible for the treatment of drug and alcohol problems) should prioritise research on the treat-
ment of drug and alcohol problems and that steps should be taken to facilitate research combined
with clinical service and research leave for doctors and psychologists involved in interdisciplinary spe-
cialist treatment of drug and alcohol problems. 
Relationship research – policy
In general, the central authorities emphasise data from research in policy documents. For instance,
it is common in such contexts to refer to surveys on the use of drugs. Similarly, evaluation is empha-
sised when testing different measures.  
Main national structures for drug-related research
Norway does not have a body dedicated to the coordination of drug and alcohol research.  SIRUS is
an independent research institute under the Ministry of Health and Care Services. In 2007, the
Ministry has also allocated funding through the Research Council of Norway to a new drug and alco-
hol research programme and a centre for drug and alcohol research at the University of Oslo.
Moreover, drug and alcohol research is also carried out by the Institute of Public Health (biomedi-
cine). Drug and alcohol research is also carried out to a certain extent at the Universities of Bergen,
Trondheim and Stavanger, at Norwegian Social Research (NOVA), at the International Research
Institute of Stavanger (IRIS) and at the Bergen Clinics Foundation.  
Drug and alcohol research is partly financed via the national budget (SIRUS, Institute of Public
Health), partly through the Research Council of Norway and partly through the Directorate for
Health and Social Affairs (various evaluation assignments) and the municipalities.
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13.2 Main recent studies and publications
Five main recent studies since 2000
(1) The drugs market
Research institute: SIRUS
Funding: SIRUS and the Ministry of Justice and the Police
Abstract: The objective of the project is to study the illegal drugs market in general and the heroin
market in Oslo in particular. The initial goal was to increase knowledge about drug prices, financ-
ing, methods of payment and total drug use among injecting  users, as well as to study these fac-
tors over time and in relation to changes in control policy measures. The aims of the project includ-
ed finding out how addicts react to fluctuations in the price of drugs, how important crimes against
property are in terms of financing drug use, how much an individual’s total drug use costs per day,
what amounts of money are involved in the illegal market etc. Another goal is to increase knowl-
edge about the seller side of the heroin market: How is the heroin market in Norway organised?
What can heroin dealers and importers tell us about the division of labour and networks in the mar-
ket? How have conditions for sellers developed over time? How do heroin dealers and importers
understand and present themselves and their activities? 
The project started in 1993 with the collection of data through regular interviews of injecting  users
recruited at the needle distribution service in Oslo city centre. This data collection is still ongoing.
The survey shows, among other things, that the nominal price of heroin and amphetamine has fall-
en dramatically during the period. 
In 2006, moreover, a qualitative study was also conducted (Snertingdal, 2007). The study was based
on 26 qualitative interviews with heroin dealers and importers. Of these, 24 were with offenders
serving prison sentences for heroin-related offences, and two were with heroin dealers on ‘the out-
side’. The main questions in the study were: How are the players recruited to the various positions
in the heroin trade and what are the players’ motives for being involved in illegal activity? The pro-
ject’s main purpose is to describe the players in the heroin trade and how they perform (See also
Part I, chapter 10.2.1).
The project is ongoing. 
Publications:
Bretteville-Jensen, A. L.: Understanding the demand for illicit drugs. An empirical approach based
on self-reported data. Dissertation in Economics No. 25. Departement of Economics, University of
Bergen 2002. 
Bretteville-Jensen, A. L.: Understanding the demand for illicit drugs. En analyse av intervjuer foretatt
1993-2004. SIRUS-report no. 4/2005 (EN summary)
Snertingdal, M. I.: Kalkulerende kjeltringer eller offer for omstendighetene? En kvalitativ studie av
heroinomsetningens utvikling og aktører. SIRUS report no.1/2007 (EN summary) 
(2) What benefit, for whom and at what cost? A prospective study of drug addicts undergoing treat-
ment
Research institute: SIRUS
Funding: SIRUS and the Research Council of Norway
Abstract: Do some treatment measures produce better results than others for different groups of
drug addicts? What is achieved through treatment seen in relation to the use of treatment resources/
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socioeconomic costs that result from the clients moving between different forms of treatment and
public institutions, such as prison? In light of the fact that many problem drug and alcohol users are
in and out of several treatment facilities, it is assumed that the result of one type of treatment may
build on what has been achieved in previous treatment(s).
The study is based on a sample of 482 clients from 20 treatment facilities who have been followed
up and interviewed using EuropASI and two forms filled in by the clients themselves (MCMI-II, SCL-
25) on admission to treatment in 1998/1999, An initial follow-up survey was conducted one year
after admission to treatment, a second follow-up survey two years after admission and a third fol-
low-up survey seven years after admission to treatment. Data from criminal records, social security
records and the Cause of Death Registry were also collected.
The project is ongoing.
Publications:
Melberg, H.O., Lauritzen, G. & Ravndal, E.: Hvilken nytte, for hvem og til hvilken kostnad? 
En prospektiv studie av stoffmisbrukere i behandling. SIRUS report no. 4/2003. (EN summary)
Melberg, H.O.: Costs and benefits of treating drug users: Essays on selection bias, contagious drug
use, the gateway hypothesis and the concept of social cost. Department of Economics, University of
Oslo. 2005 (Dissertation)
(3) Evaluation of “The action plan for alternatives to drug and alcohol milieus in Oslo city centre”
2003-2006 and the trial scheme for injection rooms.
Research institute: SIRUS
Funding: SIRUS
Abstract: In 2002, the City of Oslo presented a comprehensive action plan that aimed to disperse
the highly visible injecting  user milieus in Oslo city centre. The action plan was partly aimed at
strengthening/establishing various low threshold services, partly at improving collaboration between
the City of Oslo and Oslo Police District and between the City of Oslo and the home municipality of
drug addicts from out of town in Oslo city centre. The evaluation attempted to establish whether
the different goals of the action plan were achieved. 
The evaluation showed that the planned measures were largely implemented. However, there is no
basis for concluding that the plan contributed to the drug addicts staying away from the city cen-
tre area more than previously. The work on the plan resulted in increased collaboration between var-
ious players (see also NR 2006 chapter 7.1). 
In December 2004, the Storting passed a temporary act relating to a trial scheme for premises for
the injection of drugs, and, on 1 February 2005, an injection room was opened in Oslo. The target
group consisted of hardcore heroin addicts over the age of 18. The trial scheme is intended to facil-
itate an evaluation of the effect of freedom from prosecution for the possession and use of drugs
in a limited area (i.e. in the injection room). Otherwise, the objective of the trial scheme is to give
injecting  users a more dignified existence, increase their opportunities for contact with the help
services, contribute to preventing infections and reduce the number of overdoses and overdose
fatalities. The aim of the evaluation was to establish how and to what extent the various goals of
the trial scheme can be said to have been achieved. The evaluation also examines the role of staff.
In the first two years of operation, slightly less than 400 people made use of the injection room.
There was great variation in terms of how often the registered users of the trial scheme used the
injection room. Given that the trial scheme has been limited, there is no basis on which to draw a
conclusion as to whether the scheme has contributed to reducing infection, overdoses and overdose
fatalities.
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Publications:
Olsen, H & Skretting, A. :Ingen enkle løsninger. Evaluering av tiltaksplan for alternativer til rus-
miljøene i Oslo sentrum. SIRUS report no. 2/2006 (EN summary).
Olsen, H. & Skretting, A.: Hva nå? Evaluering av prøveordning med sprøyterom. SIRUS report no.
7/2007(EN summary). 
(4) Abstinence-oriented replacement therapy for opioid dependence.
Research institute: University of Oslo and Norwegian Knowledge Centre for the Health Services.
Funding: Not known
Abstract: The aim of the study was to assess the feasibility of short-term buprenorphine replacement
therapy programmes for dependent opioid users who were not eligible for the ordinary long-term
substitution treatment programmes. 
The research project comprised three studies. Firstly, a literature review was undertaken to assess
post-treatment abstinence rates in former patients in methadone or buprenorphine replacement
programmes. Secondly, 75 dependent opioid users in outpatient counselling were recruited to a
nine-month buprenorphine replacement programme and followed up for two years. Thirdly, 65
study participants’ personality profiles were compared with those of an age-matched norm sample. 
In the literature review, 14 studies were identified. The pooled abstinence rate across the studies was
33 per cent. For individuals who had left treatment voluntarily or on the recommendation of staff,
the pooled abstinence rate was 48 per cent, compared with 25 per cent for persons who had been
discharged involuntary or against staff recommendations. 
Forty study participants (53 %) completed the nine-month buprenorphine replacement programme.
Three non-completers died during detoxification. At two-year follow-up, the number of deaths had
increased to five. Nine participants were abstinent from all opioids (illicit and prescribed), and thir-
ty-seven participants were still in or had returned to opioid replacement therapy. The opioid-depend-
ent sample was less emotionally stable, less outgoing and less conscientious then the non-clinical
sample. 
Publication:
Dissertation, Faculty of Medicine, University of Oslo, 2007.   
(5) The cannabis market in Oslo   
Research institute: University of Oslo, Faculty of Social Science 
Funding: Not known
Abstract: The project deals with recruitment to problem drug use in central Oslo. What was the sig-
nificance of the milieu around the “Plata” area? What is happening now in relation to socialisation
into illicit drug milieus in central Oslo East? In what way are ethnic minority youth at risk?
Publication: 
Sandberg, S., Pedersen, W.: Gatekapital. Universitetsforlaget 2006. 
Peer-reviewed scientific journals
Bretteville-Jensen, A.L.: On the determinations of illicit drug use initiation, regular use and quitting.
The Economist (2006), 154 (4).
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Bretteville-Jensen, A.L.: To legalise or not to legalise? Economic approaches to the decriminalisation
of drugs. Substance Use and Misuse (2006), 41 (4). 
Bretteville-Jensen, A.L.: Unresolved issues associated with current economic models of substance
abuse. Substance Use and Misuse (2006), 41 (4). 
Pape, H., Storvoll, E.: Teenagers “use” of non-existent drugs. A study of false positives. Nordic
Studies on Alcohol and Drugs (Eng. Suppl.) (2006), 23. 
Kornør, H., Waal, H. & Ali, R.: Abstinence-oriented buprenorphine replacement therapy for young
adults in outpatient counselling. Drug and Alcohol Review 2006; 25: 123 – 130.
Kornør, H, Waal, H.  & Sandvik, L. Time-limited buprenorphine replacement therapy: 2-year follow
up outcomes in relation to program completion and current agonist status. Drug and Alcohol
Review. 2006.  
Skretting, A.: The Nordic countries and public drug-injection facilities. Drugs: education, prevention
and policy (2006) 13.
13.3 Collection and dissemination of research results
Information flows
The National Focal Point is an integrated part of SIRUS. Researchers at the institute provide data for
the national report. Data is also provided by other institutions. 
Information from the Focal Point is mainly disseminated on the website: www.sirus.no
National scientific journals
Norway has no national scientific drug research journal. 
Other national scientific journals:
• Tidsskrift for den norske legeforening, www.tidsskriftet.no (Medicine, national, peer-reviewed,
EN abstract)
• Tidsskrift for ungdomsforskning  (Adolescence,  national, peer-reviewed, EN abstract)
• Norsk psykologisk tidsskrift (Psychology, national, peer-reviewed, EN abstract)
• Tidsskrift for samfunnsforskning (Social science, national, peer-reviewed, EN abstract)
• Sosiologi i dag (Sociology, national, peer-reviewed, EN abstract)
Other means of dissemination 
Non-scientific journals:
Rus & samfunn www.rus.no
Websites dedicated to drug-related research:
www.sirus.no (SIRUS)
www.fhi.no (Norwegian Institute of Public Health)
www.uio.no/psy/skr (University of Oslo, Unit for Addiction Medicine)
www.rf.no (IRIS)
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